FI113047B - Menetelmä takykiniiniantagonisteina käyttökelpoisten substituoitujen pyrrolidin-3-yylialkyyli-piperidiinien valmistamiseksi - Google Patents
Menetelmä takykiniiniantagonisteina käyttökelpoisten substituoitujen pyrrolidin-3-yylialkyyli-piperidiinien valmistamiseksi Download PDFInfo
- Publication number
- FI113047B FI113047B FI955258A FI955258A FI113047B FI 113047 B FI113047 B FI 113047B FI 955258 A FI955258 A FI 955258A FI 955258 A FI955258 A FI 955258A FI 113047 B FI113047 B FI 113047B
- Authority
- FI
- Finland
- Prior art keywords
- ethyl
- mmol
- pyrrolidin
- dichlorophenyl
- carboxylic acid
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 196
- 230000008569 process Effects 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 102000003141 Tachykinin Human genes 0.000 title abstract description 15
- 108060008037 tachykinin Proteins 0.000 title abstract description 15
- 239000005557 antagonist Substances 0.000 title description 8
- 150000001875 compounds Chemical class 0.000 claims abstract description 310
- 150000003839 salts Chemical class 0.000 claims abstract description 34
- -1 2,6-dimethoxybenzoyl Chemical group 0.000 claims description 313
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 219
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims description 121
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 118
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 106
- 239000000203 mixture Substances 0.000 claims description 73
- 239000002253 acid Substances 0.000 claims description 37
- 150000008064 anhydrides Chemical class 0.000 claims description 35
- 125000001424 substituent group Chemical group 0.000 claims description 33
- 239000001257 hydrogen Substances 0.000 claims description 26
- 125000000217 alkyl group Chemical group 0.000 claims description 25
- 150000001412 amines Chemical class 0.000 claims description 25
- 229910052739 hydrogen Inorganic materials 0.000 claims description 25
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 21
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 19
- 150000002431 hydrogen Chemical group 0.000 claims description 18
- 238000010511 deprotection reaction Methods 0.000 claims description 17
- 150000001408 amides Chemical class 0.000 claims description 16
- 125000003545 alkoxy group Chemical group 0.000 claims description 14
- 150000002148 esters Chemical class 0.000 claims description 13
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims description 12
- 229910052736 halogen Inorganic materials 0.000 claims description 12
- 150000002367 halogens Chemical group 0.000 claims description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 10
- 229910052799 carbon Inorganic materials 0.000 claims description 9
- 101100516554 Caenorhabditis elegans nhr-5 gene Proteins 0.000 claims description 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 7
- 238000007112 amidation reaction Methods 0.000 claims description 6
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 claims description 5
- 239000007822 coupling agent Substances 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- WZMVQZJKOVPVGZ-UHFFFAOYSA-N 1-[2-[3-(3,4-dichlorophenyl)-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]ethyl]-4-phenylpiperidine-4-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCN3CCC(CC3)(C(N)=O)C=3C=CC=CC=3)(CC2)C=2C=C(Cl)C(Cl)=CC=2)=C1 WZMVQZJKOVPVGZ-UHFFFAOYSA-N 0.000 claims description 4
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 4
- 229940077388 benzenesulfonate Drugs 0.000 claims description 4
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 claims description 4
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 claims description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 3
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical group CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 claims description 2
- YEHZDBDUEDGUMK-UHFFFAOYSA-N 8-[2-[1-benzoyl-3-(3,4-dichlorophenyl)pyrrolidin-3-yl]ethyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one Chemical compound C1=C(Cl)C(Cl)=CC=C1C1(CCN2CCC3(CC2)C(NCN3C=2C=CC=CC=2)=O)CN(C(=O)C=2C=CC=CC=2)CC1 YEHZDBDUEDGUMK-UHFFFAOYSA-N 0.000 claims description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 2
- DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 claims description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 2
- 125000003386 piperidinyl group Chemical group 0.000 claims description 2
- MAPRDOKILZKGDP-UHFFFAOYSA-N bromo-chloro-iodomethanesulfonic acid Chemical compound OS(=O)(=O)C(Cl)(Br)I MAPRDOKILZKGDP-UHFFFAOYSA-N 0.000 claims 2
- 125000001475 halogen functional group Chemical group 0.000 claims 2
- SJBBXFLOLUTGCW-UHFFFAOYSA-N 1,3-bis(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC(C(F)(F)F)=C1 SJBBXFLOLUTGCW-UHFFFAOYSA-N 0.000 claims 1
- 230000009435 amidation Effects 0.000 claims 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 claims 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- MEYZYGMYMLNUHJ-UHFFFAOYSA-N tunicamycin Natural products CC(C)CCCCCCCCCC=CC(=O)NC1C(O)C(O)C(CC(O)C2OC(C(O)C2O)N3C=CC(=O)NC3=O)OC1OC4OC(CO)C(O)C(O)C4NC(=O)C MEYZYGMYMLNUHJ-UHFFFAOYSA-N 0.000 claims 1
- 230000008485 antagonism Effects 0.000 abstract description 11
- 102400000097 Neurokinin A Human genes 0.000 abstract description 10
- HEAUFJZALFKPBA-YRVBCFNBSA-N Neurokinin A Chemical compound C([C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)C(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC=1NC=NC=1)C(C)O)C1=CC=CC=C1 HEAUFJZALFKPBA-YRVBCFNBSA-N 0.000 abstract description 10
- 101800000399 Neurokinin A Proteins 0.000 abstract description 10
- 102100024304 Protachykinin-1 Human genes 0.000 abstract description 9
- 101800003906 Substance P Proteins 0.000 abstract description 9
- QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000007920 Neurogenic Inflammation Diseases 0.000 abstract description 2
- 230000000144 pharmacologic effect Effects 0.000 abstract description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 547
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 365
- 238000006243 chemical reaction Methods 0.000 description 293
- 238000003786 synthesis reaction Methods 0.000 description 284
- 230000015572 biosynthetic process Effects 0.000 description 278
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 261
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 196
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 169
- 239000000741 silica gel Substances 0.000 description 164
- 229910002027 silica gel Inorganic materials 0.000 description 164
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 128
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 121
- 239000000243 solution Substances 0.000 description 114
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 99
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 92
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical class Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 89
- 229910001868 water Inorganic materials 0.000 description 81
- 239000002904 solvent Substances 0.000 description 76
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 74
- 238000004587 chromatography analysis Methods 0.000 description 69
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 68
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 60
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 59
- 239000012074 organic phase Substances 0.000 description 59
- 238000001704 evaporation Methods 0.000 description 58
- 230000008020 evaporation Effects 0.000 description 58
- 239000000047 product Substances 0.000 description 54
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 51
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 49
- 238000000605 extraction Methods 0.000 description 48
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 47
- 238000001953 recrystallisation Methods 0.000 description 47
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 46
- 235000019341 magnesium sulphate Nutrition 0.000 description 46
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 45
- 239000012467 final product Substances 0.000 description 45
- 238000003756 stirring Methods 0.000 description 43
- 238000001665 trituration Methods 0.000 description 43
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 42
- 238000010992 reflux Methods 0.000 description 41
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 40
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 37
- 239000002585 base Substances 0.000 description 37
- NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 37
- 235000002639 sodium chloride Nutrition 0.000 description 36
- 239000002002 slurry Substances 0.000 description 35
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 34
- 239000000543 intermediate Substances 0.000 description 31
- 238000000746 purification Methods 0.000 description 31
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 30
- PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical compound CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 description 28
- 239000000460 chlorine Substances 0.000 description 28
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 27
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 27
- 238000004458 analytical method Methods 0.000 description 27
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 27
- 239000011734 sodium Substances 0.000 description 27
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 26
- 239000011541 reaction mixture Substances 0.000 description 26
- 229910000104 sodium hydride Inorganic materials 0.000 description 26
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 24
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 24
- 239000008346 aqueous phase Substances 0.000 description 22
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 22
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 21
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 21
- 125000006239 protecting group Chemical group 0.000 description 21
- 239000012312 sodium hydride Substances 0.000 description 21
- LZWFVOQSFVFPJK-UHFFFAOYSA-N 4-phenylpiperidine-4-carboxamide;hydrochloride Chemical compound Cl.C=1C=CC=CC=1C1(C(=O)N)CCNCC1 LZWFVOQSFVFPJK-UHFFFAOYSA-N 0.000 description 18
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 18
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 18
- 235000017557 sodium bicarbonate Nutrition 0.000 description 18
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 17
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 17
- 229920006395 saturated elastomer Polymers 0.000 description 17
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 17
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 16
- 150000001350 alkyl halides Chemical class 0.000 description 16
- 125000003118 aryl group Chemical group 0.000 description 16
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 16
- 150000003254 radicals Chemical class 0.000 description 16
- WRIKHQLVHPKCJU-UHFFFAOYSA-N sodium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([Na])[Si](C)(C)C WRIKHQLVHPKCJU-UHFFFAOYSA-N 0.000 description 16
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 15
- 229910052794 bromium Inorganic materials 0.000 description 15
- 239000000706 filtrate Substances 0.000 description 15
- SRZABNWAUIZJDH-UHFFFAOYSA-N 2-[3-(3,4-dichlorophenyl)pyrrolidin-3-yl]ethanol Chemical compound C=1C=C(Cl)C(Cl)=CC=1C1(CCO)CCNC1 SRZABNWAUIZJDH-UHFFFAOYSA-N 0.000 description 14
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 14
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 14
- 229910052708 sodium Inorganic materials 0.000 description 14
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 14
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 13
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 13
- 150000003053 piperidines Chemical class 0.000 description 13
- 230000002829 reductive effect Effects 0.000 description 13
- HTQWGIHCFPWKAS-UHFFFAOYSA-N 1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one Chemical compound C1CNCCC11C(=O)NCN1C1=CC=CC=C1 HTQWGIHCFPWKAS-UHFFFAOYSA-N 0.000 description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- 229910052801 chlorine Inorganic materials 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 239000012141 concentrate Substances 0.000 description 12
- 235000008504 concentrate Nutrition 0.000 description 12
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 12
- 239000012279 sodium borohydride Substances 0.000 description 12
- 229910000033 sodium borohydride Inorganic materials 0.000 description 12
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 12
- XAQGIKARGNJNSK-UHFFFAOYSA-N 2-[3-(3,4-dichlorophenyl)-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]ethyl methanesulfonate Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCOS(C)(=O)=O)(CC2)C=2C=C(Cl)C(Cl)=CC=2)=C1 XAQGIKARGNJNSK-UHFFFAOYSA-N 0.000 description 11
- 125000006242 amine protecting group Chemical group 0.000 description 11
- 239000007789 gas Substances 0.000 description 11
- 239000012044 organic layer Substances 0.000 description 11
- 229910000027 potassium carbonate Inorganic materials 0.000 description 11
- 235000011181 potassium carbonates Nutrition 0.000 description 11
- BUHYMJLFRZAFBF-UHFFFAOYSA-N 3,4,5-trimethoxybenzoyl chloride Chemical compound COC1=CC(C(Cl)=O)=CC(OC)=C1OC BUHYMJLFRZAFBF-UHFFFAOYSA-N 0.000 description 10
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 10
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 10
- 125000004494 ethyl ester group Chemical group 0.000 description 10
- 239000000284 extract Substances 0.000 description 10
- 229910052757 nitrogen Inorganic materials 0.000 description 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 10
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 10
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 9
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 9
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical class OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 9
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 9
- 235000011114 ammonium hydroxide Nutrition 0.000 description 9
- MKJDUHZPLQYUCB-UHFFFAOYSA-N decan-4-one Chemical compound CCCCCCC(=O)CCC MKJDUHZPLQYUCB-UHFFFAOYSA-N 0.000 description 9
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 9
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 8
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 8
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 8
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 8
- 239000007868 Raney catalyst Substances 0.000 description 8
- 229910000564 Raney nickel Inorganic materials 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 239000003638 chemical reducing agent Substances 0.000 description 8
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 8
- 239000012280 lithium aluminium hydride Substances 0.000 description 8
- JPUKONSIEHCAQA-UHFFFAOYSA-N 4-phenylpiperidine-4-carboxamide Chemical compound C=1C=CC=CC=1C1(C(=O)N)CCNCC1 JPUKONSIEHCAQA-UHFFFAOYSA-N 0.000 description 7
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 7
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 7
- 239000012267 brine Substances 0.000 description 7
- 239000003054 catalyst Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 150000002825 nitriles Chemical class 0.000 description 7
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 6
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 6
- DPBWFNDFMCCGGJ-UHFFFAOYSA-N 4-Piperidine carboxamide Chemical compound NC(=O)C1CCNCC1 DPBWFNDFMCCGGJ-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 6
- 235000011054 acetic acid Nutrition 0.000 description 6
- 230000029936 alkylation Effects 0.000 description 6
- 238000005804 alkylation reaction Methods 0.000 description 6
- 239000000908 ammonium hydroxide Substances 0.000 description 6
- 239000011260 aqueous acid Substances 0.000 description 6
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 6
- 125000001309 chloro group Chemical group Cl* 0.000 description 6
- 230000007062 hydrolysis Effects 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- 150000002466 imines Chemical class 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 6
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 5
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 5
- 101100516572 Caenorhabditis elegans nhr-8 gene Proteins 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical class OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- WFDIJRYMOXRFFG-UHFFFAOYSA-N acetic acid anhydride Natural products CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 5
- 239000002168 alkylating agent Substances 0.000 description 5
- 229940100198 alkylating agent Drugs 0.000 description 5
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical compound [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 5
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 5
- 229910000085 borane Inorganic materials 0.000 description 5
- WTVNFKVGGUWHQC-UHFFFAOYSA-N decane-2,4-dione Chemical compound CCCCCCC(=O)CC(C)=O WTVNFKVGGUWHQC-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- RUJPPJYDHHAEEK-UHFFFAOYSA-N ethyl piperidine-4-carboxylate Chemical compound CCOC(=O)C1CCNCC1 RUJPPJYDHHAEEK-UHFFFAOYSA-N 0.000 description 5
- 238000005984 hydrogenation reaction Methods 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- 235000011007 phosphoric acid Nutrition 0.000 description 5
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical group O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- LKVYEKLPQDBMDO-UHFFFAOYSA-N 1-[2-[1-benzoyl-3-(3,4-dichlorophenyl)pyrrolidin-3-yl]ethyl]-4-phenylpiperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)(C=2C=CC=CC=2)CCN1CCC(C1)(C=2C=C(Cl)C(Cl)=CC=2)CCN1C(=O)C1=CC=CC=C1 LKVYEKLPQDBMDO-UHFFFAOYSA-N 0.000 description 4
- JGHAJHIMCMIKPD-UHFFFAOYSA-N 1-phenyl-1,3,8-triazaspiro[4.5]decane-2,4-dione Chemical compound C=1C=CC=CC=1N1C(=O)NC(=O)C21CCNCC2 JGHAJHIMCMIKPD-UHFFFAOYSA-N 0.000 description 4
- ZJYUUAQHPGQMQO-UHFFFAOYSA-N 1-phenylpiperidine-4-carboxamide Chemical compound C1CC(C(=O)N)CCN1C1=CC=CC=C1 ZJYUUAQHPGQMQO-UHFFFAOYSA-N 0.000 description 4
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 4
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 4
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 4
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 4
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- 101100516563 Caenorhabditis elegans nhr-6 gene Proteins 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 238000007059 Strecker synthesis reaction Methods 0.000 description 4
- PVKNEZZMGKSZGR-UHFFFAOYSA-N [3-(3,4-dichlorophenyl)-3-[2-(4-phenylpiperidin-1-yl)ethyl]pyrrolidin-1-yl]-(3,4,5-trimethoxyphenyl)methanone Chemical compound ClC=1C=C(C=CC=1Cl)C1(CN(CC1)C(C1=CC(=C(C(=C1)OC)OC)OC)=O)CCN1CCC(CC1)C1=CC=CC=C1 PVKNEZZMGKSZGR-UHFFFAOYSA-N 0.000 description 4
- 235000019270 ammonium chloride Nutrition 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- TXFLGZOGNOOEFZ-UHFFFAOYSA-N bis(2-chloroethyl)amine Chemical compound ClCCNCCCl TXFLGZOGNOOEFZ-UHFFFAOYSA-N 0.000 description 4
- MCQRPQCQMGVWIQ-UHFFFAOYSA-N boron;methylsulfanylmethane Chemical compound [B].CSC MCQRPQCQMGVWIQ-UHFFFAOYSA-N 0.000 description 4
- 235000011089 carbon dioxide Nutrition 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000004296 chiral HPLC Methods 0.000 description 4
- 238000009833 condensation Methods 0.000 description 4
- 230000005494 condensation Effects 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 230000003301 hydrolyzing effect Effects 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 125000001624 naphthyl group Chemical group 0.000 description 4
- IZUPBVBPLAPZRR-UHFFFAOYSA-N pentachloro-phenol Natural products OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl IZUPBVBPLAPZRR-UHFFFAOYSA-N 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 235000017550 sodium carbonate Nutrition 0.000 description 4
- FPJWVSRNJVENGQ-UHFFFAOYSA-N tert-butyl 4-phenylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1C1=CC=CC=C1 FPJWVSRNJVENGQ-UHFFFAOYSA-N 0.000 description 4
- HJUGFYREWKUQJT-UHFFFAOYSA-N tetrabromomethane Chemical compound BrC(Br)(Br)Br HJUGFYREWKUQJT-UHFFFAOYSA-N 0.000 description 4
- 125000001544 thienyl group Chemical group 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 3
- ANKYTLJVKJPLRC-UHFFFAOYSA-N 1-[2-[3-(3,4-dichlorophenyl)-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]ethyl]-4-phenylpiperidine-4-carboxylic acid Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCN3CCC(CC3)(C(O)=O)C=3C=CC=CC=3)(CC2)C=2C=C(Cl)C(Cl)=CC=2)=C1 ANKYTLJVKJPLRC-UHFFFAOYSA-N 0.000 description 3
- LLQIQGOSJRHKTG-UHFFFAOYSA-N 1-phenylpiperidine-4-carboxamide hydrochloride Chemical compound Cl.C1(=CC=CC=C1)N1CCC(CC1)C(=O)N LLQIQGOSJRHKTG-UHFFFAOYSA-N 0.000 description 3
- GCUOLJOTJRUDIZ-UHFFFAOYSA-N 2-(2-bromoethoxy)oxane Chemical compound BrCCOC1CCCCO1 GCUOLJOTJRUDIZ-UHFFFAOYSA-N 0.000 description 3
- QWZNCAFWRZZJMA-UHFFFAOYSA-N 2-(3,4-dichlorophenyl)acetonitrile Chemical compound ClC1=CC=C(CC#N)C=C1Cl QWZNCAFWRZZJMA-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- KTSXDITVYSVNEK-UHFFFAOYSA-N 2-[1-benzoyl-3-(3,4-dichlorophenyl)pyrrolidin-3-yl]ethyl methanesulfonate Chemical compound C1C(CCOS(=O)(=O)C)(C=2C=C(Cl)C(Cl)=CC=2)CCN1C(=O)C1=CC=CC=C1 KTSXDITVYSVNEK-UHFFFAOYSA-N 0.000 description 3
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 3
- LPCWDVLDJVZIHA-UHFFFAOYSA-N 2-naphthalen-2-ylacetonitrile Chemical compound C1=CC=CC2=CC(CC#N)=CC=C21 LPCWDVLDJVZIHA-UHFFFAOYSA-N 0.000 description 3
- NKRLLPCWCPIQPL-UHFFFAOYSA-N 2-pyrrolidin-3-ylethanol Chemical class OCCC1CCNC1 NKRLLPCWCPIQPL-UHFFFAOYSA-N 0.000 description 3
- DWJTUQKCAJHQPC-UHFFFAOYSA-N 3-cyano-3-(3,4-dichlorophenyl)pentanedioic acid Chemical compound OC(=O)CC(CC(O)=O)(C#N)C1=CC=C(Cl)C(Cl)=C1 DWJTUQKCAJHQPC-UHFFFAOYSA-N 0.000 description 3
- SXXLKZCNJHJYFL-UHFFFAOYSA-N 4,5,6,7-tetrahydro-[1,2]oxazolo[4,5-c]pyridin-5-ium-3-olate Chemical compound C1CNCC2=C1ONC2=O SXXLKZCNJHJYFL-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 101000799461 Homo sapiens Thrombopoietin Proteins 0.000 description 3
- 229910010084 LiAlH4 Inorganic materials 0.000 description 3
- NHXYSAFTNPANFK-HDMCBQFHSA-N Neurokinin B Chemical compound C([C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CC(O)=O)C1=CC=CC=C1 NHXYSAFTNPANFK-HDMCBQFHSA-N 0.000 description 3
- 102000046798 Neurokinin B Human genes 0.000 description 3
- 108010040722 Neurokinin-2 Receptors Proteins 0.000 description 3
- 101800002813 Neurokinin-B Proteins 0.000 description 3
- 102100037342 Substance-K receptor Human genes 0.000 description 3
- 102100034195 Thrombopoietin Human genes 0.000 description 3
- JGGRFGGHFAYVHR-UHFFFAOYSA-N [3-(3,4-dichlorophenyl)-3-(2-hydroxyethyl)pyrrolidin-1-yl]-(2-methoxyphenyl)methanone Chemical compound COC1=CC=CC=C1C(=O)N1CC(CCO)(C=2C=C(Cl)C(Cl)=CC=2)CC1 JGGRFGGHFAYVHR-UHFFFAOYSA-N 0.000 description 3
- JNONVJIHARIPTQ-UHFFFAOYSA-N [3-(3,4-dichlorophenyl)-3-(2-hydroxyethyl)pyrrolidin-1-yl]-(3,4,5-trimethoxyphenyl)methanone Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCO)(CC2)C=2C=C(Cl)C(Cl)=CC=2)=C1 JNONVJIHARIPTQ-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical class ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 3
- 125000001246 bromo group Chemical group Br* 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 125000000068 chlorophenyl group Chemical group 0.000 description 3
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 3
- XLJKHNWPARRRJB-UHFFFAOYSA-N cobalt(2+) Chemical compound [Co+2] XLJKHNWPARRRJB-UHFFFAOYSA-N 0.000 description 3
- NNFCIYWJLLJEMN-UHFFFAOYSA-N dec-2-en-4-one Chemical compound CCCCCCC(=O)C=CC NNFCIYWJLLJEMN-UHFFFAOYSA-N 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 125000004188 dichlorophenyl group Chemical group 0.000 description 3
- QKIUAMUSENSFQQ-UHFFFAOYSA-N dimethylazanide Chemical compound C[N-]C QKIUAMUSENSFQQ-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 125000001207 fluorophenyl group Chemical group 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- VOAPTKOANCCNFV-UHFFFAOYSA-N hexahydrate;hydrochloride Chemical compound O.O.O.O.O.O.Cl VOAPTKOANCCNFV-UHFFFAOYSA-N 0.000 description 3
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 3
- 125000002346 iodo group Chemical group I* 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 150000004702 methyl esters Chemical class 0.000 description 3
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- FSDNTQSJGHSJBG-UHFFFAOYSA-N piperidine-4-carbonitrile Chemical compound N#CC1CCNCC1 FSDNTQSJGHSJBG-UHFFFAOYSA-N 0.000 description 3
- FQZLNQAUUMSUHT-UHFFFAOYSA-N tert-butyl n,n-bis(2-chloroethyl)carbamate Chemical compound CC(C)(C)OC(=O)N(CCCl)CCCl FQZLNQAUUMSUHT-UHFFFAOYSA-N 0.000 description 3
- 230000024883 vasodilation Effects 0.000 description 3
- AYKYOOPFBCOXSL-UHFFFAOYSA-N (4-hydroxyphenyl)acetonitrile Chemical compound OC1=CC=C(CC#N)C=C1 AYKYOOPFBCOXSL-UHFFFAOYSA-N 0.000 description 2
- WDQFELCEOPFLCZ-UHFFFAOYSA-N 1-(2-hydroxyethyl)pyrrolidin-2-one Chemical compound OCCN1CCCC1=O WDQFELCEOPFLCZ-UHFFFAOYSA-N 0.000 description 2
- SYIVVGOSXRAAKP-UHFFFAOYSA-N 1-(2-pyrrolidin-3-ylethyl)piperidine Chemical class C1CNCC1CCN1CCCCC1 SYIVVGOSXRAAKP-UHFFFAOYSA-N 0.000 description 2
- BEEPXSBZGLKIOT-UHFFFAOYSA-N 1-(4-fluorophenyl)-1,3,8-triazaspiro[4.5]decan-4-one Chemical compound C1=CC(F)=CC=C1N1C2(CCNCC2)C(=O)NC1 BEEPXSBZGLKIOT-UHFFFAOYSA-N 0.000 description 2
- ZDWOYDIXKYSZPX-UHFFFAOYSA-N 1-[(2-methylpropan-2-yl)oxycarbonyl]-4-phenylpiperidine-4-carboxylic acid Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1(C(O)=O)C1=CC=CC=C1 ZDWOYDIXKYSZPX-UHFFFAOYSA-N 0.000 description 2
- IMBSBBYXUJKHRR-UHFFFAOYSA-N 1-[(2-methylpropan-2-yl)oxycarbonyl]-4-pyridin-2-ylpiperidine-4-carboxylic acid Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1(C(O)=O)C1=CC=CC=N1 IMBSBBYXUJKHRR-UHFFFAOYSA-N 0.000 description 2
- ZURDRHAPGPNQOT-UHFFFAOYSA-N 1-[(2-methylpropan-2-yl)oxycarbonyl]-4-pyridin-4-ylpiperidine-4-carboxylic acid Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1(C(O)=O)C1=CC=NC=C1 ZURDRHAPGPNQOT-UHFFFAOYSA-N 0.000 description 2
- GFELCGJBQGNHBL-UHFFFAOYSA-N 1-[2-[3-(3,4-dichlorophenyl)-1-(2,6-dimethoxybenzoyl)pyrrolidin-3-yl]ethyl]-4-phenylpiperidine-4-carboxamide Chemical compound COC1=CC=CC(OC)=C1C(=O)N1CC(CCN2CCC(CC2)(C(N)=O)C=2C=CC=CC=2)(C=2C=C(Cl)C(Cl)=CC=2)CC1 GFELCGJBQGNHBL-UHFFFAOYSA-N 0.000 description 2
- VMXIXFZELDQUJS-UHFFFAOYSA-N 1-[2-[3-(3,4-dichlorophenyl)-1-(2-methoxybenzoyl)pyrrolidin-3-yl]ethyl]-4-phenylpiperidine-4-carboxamide Chemical compound COC1=CC=CC=C1C(=O)N1CC(CCN2CCC(CC2)(C(N)=O)C=2C=CC=CC=2)(C=2C=C(Cl)C(Cl)=CC=2)CC1 VMXIXFZELDQUJS-UHFFFAOYSA-N 0.000 description 2
- UEISAAVLLGYCLP-UHFFFAOYSA-N 1-[2-[3-(3,4-dichlorophenyl)-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]ethyl]-4-phenylpiperidine-4-carboxylic acid;piperidine-1-carboxamide Chemical compound NC(=O)N1CCCCC1.COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCN3CCC(CC3)(C(O)=O)C=3C=CC=CC=3)(CC2)C=2C=C(Cl)C(Cl)=CC=2)=C1 UEISAAVLLGYCLP-UHFFFAOYSA-N 0.000 description 2
- HPRPQPRCKSBECC-UHFFFAOYSA-N 1-[2-[3-(3,4-dichlorophenyl)-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]ethyl]-n-[2-(dimethylamino)ethyl]-4-phenylpiperidine-4-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCN3CCC(CC3)(C(=O)NCCN(C)C)C=3C=CC=CC=3)(CC2)C=2C=C(Cl)C(Cl)=CC=2)=C1 HPRPQPRCKSBECC-UHFFFAOYSA-N 0.000 description 2
- ZKGRNGWUBQYAGP-UHFFFAOYSA-N 1-[2-[3-(3,4-dichlorophenyl)-1-(3,5-dimethoxybenzoyl)pyrrolidin-3-yl]ethyl]-4-phenylpiperidine-4-carboxamide Chemical compound COC1=CC(OC)=CC(C(=O)N2CC(CCN3CCC(CC3)(C(N)=O)C=3C=CC=CC=3)(CC2)C=2C=C(Cl)C(Cl)=CC=2)=C1 ZKGRNGWUBQYAGP-UHFFFAOYSA-N 0.000 description 2
- WLEZSTFPNISHOJ-UHFFFAOYSA-N 1-[2-[3-(3,4-dichlorophenyl)-1-(pyridine-2-carbonyl)pyrrolidin-3-yl]ethyl]-4-phenylpiperidine-4-carboxamide Chemical compound C1CC(C(=O)N)(C=2C=CC=CC=2)CCN1CCC(C1)(C=2C=C(Cl)C(Cl)=CC=2)CCN1C(=O)C1=CC=CC=N1 WLEZSTFPNISHOJ-UHFFFAOYSA-N 0.000 description 2
- FMTLSROFQVSZGR-UHFFFAOYSA-N 1-[2-[3-(3,4-dimethoxyphenyl)-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]ethyl]-4-phenylpiperidine-4-carboxamide Chemical compound C1=C(OC)C(OC)=CC=C1C1(CCN2CCC(CC2)(C(N)=O)C=2C=CC=CC=2)CN(C(=O)C=2C=C(OC)C(OC)=C(OC)C=2)CC1 FMTLSROFQVSZGR-UHFFFAOYSA-N 0.000 description 2
- BLWGUFZKABRLPD-UHFFFAOYSA-N 1-phenyl-1,3,8-triazaspiro[4.5]dec-2-en-4-one Chemical compound C1CNCCC11C(=O)N=CN1C1=CC=CC=C1 BLWGUFZKABRLPD-UHFFFAOYSA-N 0.000 description 2
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 2
- COLSEUGTAVPLDY-UHFFFAOYSA-N 2-(3-thiophen-2-ylpyrrolidin-3-yl)ethanol Chemical compound C=1C=CSC=1C1(CCO)CCNC1 COLSEUGTAVPLDY-UHFFFAOYSA-N 0.000 description 2
- OXQGTIUCKGYOAA-UHFFFAOYSA-N 2-Ethylbutanoic acid Chemical compound CCC(CC)C(O)=O OXQGTIUCKGYOAA-UHFFFAOYSA-N 0.000 description 2
- AUJPCMSBYVXXEP-UHFFFAOYSA-N 2-[3-(1,3-benzodioxol-5-yl)pyrrolidin-3-yl]ethanol Chemical compound C=1C=C2OCOC2=CC=1C1(CCO)CCNC1 AUJPCMSBYVXXEP-UHFFFAOYSA-N 0.000 description 2
- HAVWPSVPZLNNAG-UHFFFAOYSA-N 2-[3-(2-fluorophenyl)pyrrolidin-3-yl]ethanol Chemical compound C=1C=CC=C(F)C=1C1(CCO)CCNC1 HAVWPSVPZLNNAG-UHFFFAOYSA-N 0.000 description 2
- FFXAUNAHMRMWCS-UHFFFAOYSA-N 2-[3-(3,4-dichlorophenyl)-1-(2,6-dimethoxybenzoyl)pyrrolidin-3-yl]ethyl methanesulfonate Chemical compound COC1=CC=CC(OC)=C1C(=O)N1CC(CCOS(C)(=O)=O)(C=2C=C(Cl)C(Cl)=CC=2)CC1 FFXAUNAHMRMWCS-UHFFFAOYSA-N 0.000 description 2
- NIRMPTMVMMHHJB-UHFFFAOYSA-N 2-[3-(3,4-dichlorophenyl)-1-(2-methoxybenzoyl)pyrrolidin-3-yl]ethyl methanesulfonate Chemical compound COC1=CC=CC=C1C(=O)N1CC(CCOS(C)(=O)=O)(C=2C=C(Cl)C(Cl)=CC=2)CC1 NIRMPTMVMMHHJB-UHFFFAOYSA-N 0.000 description 2
- YPZZIHXYDXTDJB-UHFFFAOYSA-N 2-[3-(3,4-dimethoxyphenyl)-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]ethyl methanesulfonate Chemical compound C1=C(OC)C(OC)=CC=C1C1(CCOS(C)(=O)=O)CN(C(=O)C=2C=C(OC)C(OC)=C(OC)C=2)CC1 YPZZIHXYDXTDJB-UHFFFAOYSA-N 0.000 description 2
- PDOOSTCOXCCMEG-UHFFFAOYSA-N 2-[3-[3-(trifluoromethyl)phenyl]pyrrolidin-3-yl]ethanol Chemical compound C=1C=CC(C(F)(F)F)=CC=1C1(CCO)CCNC1 PDOOSTCOXCCMEG-UHFFFAOYSA-N 0.000 description 2
- LILCYGWMJUABFA-UHFFFAOYSA-N 2-[3-[4-(trifluoromethyl)phenyl]pyrrolidin-3-yl]ethanol Chemical compound C=1C=C(C(F)(F)F)C=CC=1C1(CCO)CCNC1 LILCYGWMJUABFA-UHFFFAOYSA-N 0.000 description 2
- MWFMGBPGAXYFAR-UHFFFAOYSA-N 2-hydroxy-2-methylpropanenitrile Chemical compound CC(C)(O)C#N MWFMGBPGAXYFAR-UHFFFAOYSA-N 0.000 description 2
- RZNHSEZOLFEFGB-UHFFFAOYSA-N 2-methoxybenzoyl chloride Chemical compound COC1=CC=CC=C1C(Cl)=O RZNHSEZOLFEFGB-UHFFFAOYSA-N 0.000 description 2
- OIPHWUPMXHQWLR-UHFFFAOYSA-N 2-pyridin-3-ylacetonitrile Chemical compound N#CCC1=CC=CN=C1 OIPHWUPMXHQWLR-UHFFFAOYSA-N 0.000 description 2
- SDXAWLJRERMRKF-UHFFFAOYSA-N 3,5-dimethyl-1h-pyrazole Chemical compound CC=1C=C(C)NN=1 SDXAWLJRERMRKF-UHFFFAOYSA-N 0.000 description 2
- HQHZEQCBQADPSO-UHFFFAOYSA-N 3-(3,4-dimethoxyphenyl)pyrrolidine Chemical compound C1=C(OC)C(OC)=CC=C1C1CNCC1 HQHZEQCBQADPSO-UHFFFAOYSA-N 0.000 description 2
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- JLAKCHGEEBPDQI-UHFFFAOYSA-N 4-(4-fluorobenzyl)piperidine Chemical compound C1=CC(F)=CC=C1CC1CCNCC1 JLAKCHGEEBPDQI-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- XDCOYBQVEVSNNB-UHFFFAOYSA-N 4-[(7-naphthalen-2-yl-1-benzothiophen-2-yl)methylamino]butanoic acid Chemical compound OC(=O)CCCNCc1cc2cccc(-c3ccc4ccccc4c3)c2s1 XDCOYBQVEVSNNB-UHFFFAOYSA-N 0.000 description 2
- KJFHZNWUTBKQRS-UHFFFAOYSA-N 4-[4-[tert-butyl(dimethyl)silyl]oxyphenyl]-4-(2-hydroxyethyl)pyrrolidin-2-one Chemical compound C1=CC(O[Si](C)(C)C(C)(C)C)=CC=C1C1(CCO)CC(=O)NC1 KJFHZNWUTBKQRS-UHFFFAOYSA-N 0.000 description 2
- QGBUYDYTQPOXKF-UHFFFAOYSA-N 4-benzyl-1-[2-[3-(3,4-dichlorophenyl)-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]ethyl]piperidine-4-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCN3CCC(CC=4C=CC=CC=4)(CC3)C(N)=O)(CC2)C=2C=C(Cl)C(Cl)=CC=2)=C1 QGBUYDYTQPOXKF-UHFFFAOYSA-N 0.000 description 2
- 125000000242 4-chlorobenzoyl group Chemical group ClC1=CC=C(C(=O)*)C=C1 0.000 description 2
- DFMMRIIKFLAKHN-UHFFFAOYSA-N 4-naphthalen-2-yl-4-[2-(oxan-2-yloxy)ethyl]pyrrolidin-2-one Chemical compound C1NC(=O)CC1(C=1C=C2C=CC=CC2=CC=1)CCOC1OCCCC1 DFMMRIIKFLAKHN-UHFFFAOYSA-N 0.000 description 2
- PRCRNQCYFGJYQF-UHFFFAOYSA-N 4-naphthalen-2-ylpiperidine-4-carbonitrile;hydrochloride Chemical compound Cl.C=1C=C2C=CC=CC2=CC=1C1(C#N)CCNCC1 PRCRNQCYFGJYQF-UHFFFAOYSA-N 0.000 description 2
- GAYSSSWAXYDKOH-UHFFFAOYSA-N 4-naphthalen-2-ylpiperidine-4-carboxamide;hydrochloride Chemical compound Cl.C=1C=C2C=CC=CC2=CC=1C1(C(=O)N)CCNCC1 GAYSSSWAXYDKOH-UHFFFAOYSA-N 0.000 description 2
- LAPFOXIAMPWEOW-UHFFFAOYSA-N 4-naphthalen-2-ylpiperidine-4-carboxylic acid;hydrochloride Chemical compound Cl.C=1C=C2C=CC=CC2=CC=1C1(C(=O)O)CCNCC1 LAPFOXIAMPWEOW-UHFFFAOYSA-N 0.000 description 2
- SSAMSPDTZGHJSP-UHFFFAOYSA-N 4-pyridin-3-ylpiperidine-4-carbonitrile;hydrochloride Chemical compound Cl.C=1C=CN=CC=1C1(C#N)CCNCC1 SSAMSPDTZGHJSP-UHFFFAOYSA-N 0.000 description 2
- BNKYHIFBHHECAR-UHFFFAOYSA-N 4-pyridin-3-ylpiperidine-4-carboxylic acid;hydrochloride Chemical compound Cl.C=1C=CN=CC=1C1(C(=O)O)CCNCC1 BNKYHIFBHHECAR-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- FQVHBTGZBRFGLK-UHFFFAOYSA-N 8-benzyl-1-(4-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-2-en-4-one Chemical compound C1=CC(F)=CC=C1N1C2(CCN(CC=3C=CC=CC=3)CC2)C(=O)N=C1 FQVHBTGZBRFGLK-UHFFFAOYSA-N 0.000 description 2
- 240000000662 Anethum graveolens Species 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- 206010006482 Bronchospasm Diseases 0.000 description 2
- GKPLDMILIKWHIV-UHFFFAOYSA-N C1=CC(=CC(=C1)C(F)(F)F)C(CC(=O)O)(CC(=O)O)C#N Chemical compound C1=CC(=CC(=C1)C(F)(F)F)C(CC(=O)O)(CC(=O)O)C#N GKPLDMILIKWHIV-UHFFFAOYSA-N 0.000 description 2
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 description 2
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- ASMQGLCHMVWBQR-UHFFFAOYSA-N Diphenyl phosphate Chemical compound C=1C=CC=CC=1OP(=O)(O)OC1=CC=CC=C1 ASMQGLCHMVWBQR-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 2
- 108010040718 Neurokinin-1 Receptors Proteins 0.000 description 2
- 102000002002 Neurokinin-1 Receptors Human genes 0.000 description 2
- 108090000189 Neuropeptides Proteins 0.000 description 2
- DZZGGKPKWGPNJA-UHFFFAOYSA-N Normeperidinicacid Chemical compound C=1C=CC=CC=1C1(C(=O)O)CCNCC1 DZZGGKPKWGPNJA-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- 102000007124 Tachykinin Receptors Human genes 0.000 description 2
- 108010072901 Tachykinin Receptors Proteins 0.000 description 2
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 2
- DDSUXAKLSCKEIC-UHFFFAOYSA-N [3-(1,3-benzodioxol-5-yl)-3-(2-hydroxyethyl)pyrrolidin-1-yl]-(3,4,5-trimethoxyphenyl)methanone Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCO)(CC2)C=2C=C3OCOC3=CC=2)=C1 DDSUXAKLSCKEIC-UHFFFAOYSA-N 0.000 description 2
- QIGGYYBNFCUDRJ-UHFFFAOYSA-N [3-(2-hydroxyethyl)-3-naphthalen-2-ylpyrrolidin-1-yl]-phenylmethanone Chemical compound C1C(CCO)(C=2C=C3C=CC=CC3=CC=2)CCN1C(=O)C1=CC=CC=C1 QIGGYYBNFCUDRJ-UHFFFAOYSA-N 0.000 description 2
- NOMAEWHUCRYCAN-UHFFFAOYSA-N [3-(2-hydroxyethyl)-3-thiophen-2-ylpyrrolidin-1-yl]-(3,4,5-trimethoxyphenyl)methanone Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCO)(CC2)C=2SC=CC=2)=C1 NOMAEWHUCRYCAN-UHFFFAOYSA-N 0.000 description 2
- KVOJJESUHWYJTC-UHFFFAOYSA-N [3-(3,4-dichlorophenyl)-3-(2-hydroxyethyl)pyrrolidin-1-yl]-(2,4-dimethoxyphenyl)methanone Chemical compound COC1=CC(OC)=CC=C1C(=O)N1CC(CCO)(C=2C=C(Cl)C(Cl)=CC=2)CC1 KVOJJESUHWYJTC-UHFFFAOYSA-N 0.000 description 2
- YHBRVXPBIZQEGC-UHFFFAOYSA-N [3-(3,4-dichlorophenyl)-3-(2-hydroxyethyl)pyrrolidin-1-yl]-phenylmethanone Chemical compound C1C(CCO)(C=2C=C(Cl)C(Cl)=CC=2)CCN1C(=O)C1=CC=CC=C1 YHBRVXPBIZQEGC-UHFFFAOYSA-N 0.000 description 2
- RMVPUFLZFXKDOB-UHFFFAOYSA-N [3-(3,4-dimethoxyphenyl)-3-(2-hydroxyethyl)pyrrolidin-1-yl]-(3,4,5-trimethoxyphenyl)methanone Chemical compound C1=C(OC)C(OC)=CC=C1C1(CCO)CN(C(=O)C=2C=C(OC)C(OC)=C(OC)C=2)CC1 RMVPUFLZFXKDOB-UHFFFAOYSA-N 0.000 description 2
- DSVGQVZAZSZEEX-UHFFFAOYSA-N [C].[Pt] Chemical compound [C].[Pt] DSVGQVZAZSZEEX-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 210000003423 ankle Anatomy 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 230000007885 bronchoconstriction Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 229910021386 carbon form Inorganic materials 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229940068911 chloride hexahydrate Drugs 0.000 description 2
- QOPVNWQGBQYBBP-UHFFFAOYSA-N chloroethyl chloroformate Chemical compound CC(Cl)OC(Cl)=O QOPVNWQGBQYBBP-UHFFFAOYSA-N 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- WRJWRGBVPUUDLA-UHFFFAOYSA-N chlorosulfonyl isocyanate Chemical compound ClS(=O)(=O)N=C=O WRJWRGBVPUUDLA-UHFFFAOYSA-N 0.000 description 2
- GFHNAMRJFCEERV-UHFFFAOYSA-L cobalt chloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].[Cl-].[Co+2] GFHNAMRJFCEERV-UHFFFAOYSA-L 0.000 description 2
- 229940125773 compound 10 Drugs 0.000 description 2
- 229940125898 compound 5 Drugs 0.000 description 2
- OCXGTPDKNBIOTF-UHFFFAOYSA-N dibromo(triphenyl)-$l^{5}-phosphane Chemical compound C=1C=CC=CC=1P(Br)(C=1C=CC=CC=1)(Br)C1=CC=CC=C1 OCXGTPDKNBIOTF-UHFFFAOYSA-N 0.000 description 2
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- QLOQOBYSCQBJDC-UHFFFAOYSA-N ethyl 2-[3-(2-fluorophenyl)-5-oxopyrrolidin-3-yl]acetate Chemical compound C=1C=CC=C(F)C=1C1(CC(=O)OCC)CNC(=O)C1 QLOQOBYSCQBJDC-UHFFFAOYSA-N 0.000 description 2
- WAJMDVULEPZWLL-UHFFFAOYSA-N ethyl 2-[3-(3,4-dichlorophenyl)-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]acetate Chemical compound C1C(CC(=O)OCC)(C=2C=C(Cl)C(Cl)=CC=2)CCN1C(=O)C1=CC(OC)=C(OC)C(OC)=C1 WAJMDVULEPZWLL-UHFFFAOYSA-N 0.000 description 2
- MMMBNFVTJSJJNN-UHFFFAOYSA-N ethyl 2-[3-(3,4-dichlorophenyl)-5-oxopyrrolidin-3-yl]acetate Chemical compound C=1C=C(Cl)C(Cl)=CC=1C1(CC(=O)OCC)CNC(=O)C1 MMMBNFVTJSJJNN-UHFFFAOYSA-N 0.000 description 2
- AYUJZKMLOXYAAZ-UHFFFAOYSA-N ethyl 2-[5-oxo-3-[3-(trifluoromethyl)phenyl]pyrrolidin-3-yl]acetate Chemical compound C=1C=CC(C(F)(F)F)=CC=1C1(CC(=O)OCC)CNC(=O)C1 AYUJZKMLOXYAAZ-UHFFFAOYSA-N 0.000 description 2
- QKYKUDJXZJWOOS-UHFFFAOYSA-N ethyl 3-cyano-3-(3,4-dichlorophenyl)-5-(oxan-2-yloxy)pentanoate Chemical compound C=1C=C(Cl)C(Cl)=CC=1C(CC(=O)OCC)(C#N)CCOC1CCCCO1 QKYKUDJXZJWOOS-UHFFFAOYSA-N 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- JFCQEDHGNNZCLN-UHFFFAOYSA-N glutaric acid Chemical compound OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 150000004678 hydrides Chemical class 0.000 description 2
- SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical compound OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 2
- VSNWCTNBFRAGLG-UHFFFAOYSA-N methyl 4-phenylpiperidine-4-carboxylate;hydrochloride Chemical compound Cl.C=1C=CC=CC=1C1(C(=O)OC)CCNCC1 VSNWCTNBFRAGLG-UHFFFAOYSA-N 0.000 description 2
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 description 2
- ZKWFSTHEYLJLEL-UHFFFAOYSA-N morpholine-4-carboxamide Chemical compound NC(=O)N1CCOCC1 ZKWFSTHEYLJLEL-UHFFFAOYSA-N 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 201000008482 osteoarthritis Diseases 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- SUSQOBVLVYHIEX-UHFFFAOYSA-N phenylacetonitrile Chemical compound N#CCC1=CC=CC=C1 SUSQOBVLVYHIEX-UHFFFAOYSA-N 0.000 description 2
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 229960000948 quinine Drugs 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 230000016160 smooth muscle contraction Effects 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- TZODONUATMTJPI-UHFFFAOYSA-N tert-butyl 2-ethylpiperidine-1-carboxylate Chemical compound CCC1CCCCN1C(=O)OC(C)(C)C TZODONUATMTJPI-UHFFFAOYSA-N 0.000 description 2
- ZNICOTLOPCODTO-UHFFFAOYSA-N tert-butyl 3-butylpiperazine-1-carboxylate Chemical compound CCCCC1CN(C(=O)OC(C)(C)C)CCN1 ZNICOTLOPCODTO-UHFFFAOYSA-N 0.000 description 2
- YJTHFKMWAUAXDX-UHFFFAOYSA-N tert-butyl 4-benzylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1CC1=CC=CC=C1 YJTHFKMWAUAXDX-UHFFFAOYSA-N 0.000 description 2
- YFFNTRHCIKUMCA-UHFFFAOYSA-N tert-butyl 4-carbamoyl-4-phenylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1(C(N)=O)C1=CC=CC=C1 YFFNTRHCIKUMCA-UHFFFAOYSA-N 0.000 description 2
- RNBYPJZFWOSEBG-UHFFFAOYSA-N tert-butyl 4-carbamoyl-4-pyridin-2-ylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1(C(N)=O)C1=CC=CC=N1 RNBYPJZFWOSEBG-UHFFFAOYSA-N 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- 150000003536 tetrazoles Chemical class 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 150000003852 triazoles Chemical class 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 229910052720 vanadium Inorganic materials 0.000 description 2
- VOLGAXAGEUPBDM-UHFFFAOYSA-N $l^{1}-oxidanylethane Chemical compound CC[O] VOLGAXAGEUPBDM-UHFFFAOYSA-N 0.000 description 1
- ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 description 1
- SHAHPWSYJFYMRX-GDLCADMTSA-N (2S)-2-(4-{[(1R,2S)-2-hydroxycyclopentyl]methyl}phenyl)propanoic acid Chemical compound C1=CC([C@@H](C(O)=O)C)=CC=C1C[C@@H]1[C@@H](O)CCC1 SHAHPWSYJFYMRX-GDLCADMTSA-N 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- GPQDTQQOCVLGTC-UHFFFAOYSA-N 1,2,3-triazaspiro[4.5]decan-4-one Chemical compound O=C1NNNC11CCCCC1 GPQDTQQOCVLGTC-UHFFFAOYSA-N 0.000 description 1
- JRKPNHLSQGAUDY-UHFFFAOYSA-N 1,3,8-triazaspiro[4.5]decan-4-one Chemical compound O=C1NCNC11CCNCC1 JRKPNHLSQGAUDY-UHFFFAOYSA-N 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- ICZLQHLWWMQTRJ-UHFFFAOYSA-N 1-(4-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-2-en-4-one;hydrochloride Chemical compound Cl.C1=CC(F)=CC=C1N1C2(CCNCC2)C(=O)N=C1 ICZLQHLWWMQTRJ-UHFFFAOYSA-N 0.000 description 1
- CKNIJZASVYHYEF-UHFFFAOYSA-N 1-(4-fluorophenyl)-1,3,8-triazaspiro[4.5]decane Chemical compound C1=CC(F)=CC=C1N1C2(CCNCC2)CNC1 CKNIJZASVYHYEF-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- RBVVHXWOHCLKDW-UHFFFAOYSA-N 1-[(2-methylpropan-2-yl)oxycarbonyl]-4-naphthalen-2-ylpiperidine-4-carboxylic acid Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1(C(O)=O)C1=CC=C(C=CC=C2)C2=C1 RBVVHXWOHCLKDW-UHFFFAOYSA-N 0.000 description 1
- JHJNEMCXXDMXAV-UHFFFAOYSA-N 1-[2-(1-benzoyl-3-naphthalen-2-ylpyrrolidin-3-yl)ethyl]-4-phenylpiperidine-4-carboxamide Chemical compound C1CC(C(=O)N)(C=2C=CC=CC=2)CCN1CCC(C1)(C=2C=C3C=CC=CC3=CC=2)CCN1C(=O)C1=CC=CC=C1 JHJNEMCXXDMXAV-UHFFFAOYSA-N 0.000 description 1
- JMIKNHGMALLEMU-UHFFFAOYSA-N 1-[2-[1-benzoyl-3-(3,4-dichlorophenyl)pyrrolidin-3-yl]ethyl]-4-phenylpiperidine-4-carboxamide Chemical compound C1CC(C(=O)N)(C=2C=CC=CC=2)CCN1CCC(C1)(C=2C=C(Cl)C(Cl)=CC=2)CCN1C(=O)C1=CC=CC=C1 JMIKNHGMALLEMU-UHFFFAOYSA-N 0.000 description 1
- SMOJLGPUWYJRQV-UHFFFAOYSA-N 1-[2-[3-(2-fluorophenyl)-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]ethyl]-4-phenylpiperidine-4-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCN3CCC(CC3)(C(N)=O)C=3C=CC=CC=3)(CC2)C=2C(=CC=CC=2)F)=C1 SMOJLGPUWYJRQV-UHFFFAOYSA-N 0.000 description 1
- XWPYGVSIKQQKGZ-UHFFFAOYSA-N 1-[2-[3-(3,4-dichlorophenyl)-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]ethyl]-4-phenylpiperidine-4-carboxylic acid;morpholine-4-carboxamide Chemical compound NC(=O)N1CCOCC1.COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCN3CCC(CC3)(C(O)=O)C=3C=CC=CC=3)(CC2)C=2C=C(Cl)C(Cl)=CC=2)=C1 XWPYGVSIKQQKGZ-UHFFFAOYSA-N 0.000 description 1
- ZVCKQEAQHRYUTH-UHFFFAOYSA-N 1-[2-[3-(3,4-dichlorophenyl)-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]ethyl]-4-phenylpiperidine-4-carboxylic acid;pyrrolidine-1-carboxamide Chemical compound NC(=O)N1CCCC1.COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCN3CCC(CC3)(C(O)=O)C=3C=CC=CC=3)(CC2)C=2C=C(Cl)C(Cl)=CC=2)=C1 ZVCKQEAQHRYUTH-UHFFFAOYSA-N 0.000 description 1
- PINXYVGXMYFCOO-UHFFFAOYSA-N 1-[2-[3-(3,4-dichlorophenyl)-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]ethyl]-4-pyridin-4-ylpiperidine-4-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCN3CCC(CC3)(C(N)=O)C=3C=CN=CC=3)(CC2)C=2C=C(Cl)C(Cl)=CC=2)=C1 PINXYVGXMYFCOO-UHFFFAOYSA-N 0.000 description 1
- DRZNPWMNXVJENS-UHFFFAOYSA-N 1-[2-[3-(3,4-dichlorophenyl)-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]ethyl]-n,n-dimethyl-4-phenylpiperidine-4-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCN3CCC(CC3)(C(=O)N(C)C)C=3C=CC=CC=3)(CC2)C=2C=C(Cl)C(Cl)=CC=2)=C1 DRZNPWMNXVJENS-UHFFFAOYSA-N 0.000 description 1
- WICHADTVCQKZOS-UHFFFAOYSA-N 1-[2-[3-(3,4-dichlorophenyl)-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]ethyl]-n-methyl-4-phenylpiperidine-4-carboxamide Chemical compound C1CC(C(=O)NC)(C=2C=CC=CC=2)CCN1CCC(C1)(C=2C=C(Cl)C(Cl)=CC=2)CCN1C(=O)C1=CC(OC)=C(OC)C(OC)=C1 WICHADTVCQKZOS-UHFFFAOYSA-N 0.000 description 1
- GUUBAKCFURYWAZ-UHFFFAOYSA-N 1-[2-[3-(3,4-dichlorophenyl)-1-(3-methoxybenzoyl)pyrrolidin-3-yl]ethyl]-4-phenylpiperidine-4-carboxamide Chemical compound COC1=CC=CC(C(=O)N2CC(CCN3CCC(CC3)(C(N)=O)C=3C=CC=CC=3)(CC2)C=2C=C(Cl)C(Cl)=CC=2)=C1 GUUBAKCFURYWAZ-UHFFFAOYSA-N 0.000 description 1
- YCMAOHLEJMWCLX-UHFFFAOYSA-N 1-[2-[3-(3,4-dichlorophenyl)-1-[2-(2-methoxyphenyl)acetyl]pyrrolidin-3-yl]ethyl]-4-phenylpiperidine-4-carboxamide Chemical compound COC1=CC=CC=C1CC(=O)N1CC(CCN2CCC(CC2)(C(N)=O)C=2C=CC=CC=2)(C=2C=C(Cl)C(Cl)=CC=2)CC1 YCMAOHLEJMWCLX-UHFFFAOYSA-N 0.000 description 1
- RGSKEIMNARYZLJ-UHFFFAOYSA-N 1-[2-[3-(3,4-dichlorophenyl)-5-oxo-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]ethyl]-4-phenylpiperidine-4-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2C(CC(CCN3CCC(CC3)(C(N)=O)C=3C=CC=CC=3)(C2)C=2C=C(Cl)C(Cl)=CC=2)=O)=C1 RGSKEIMNARYZLJ-UHFFFAOYSA-N 0.000 description 1
- CRJKLZNSICTFRV-UHFFFAOYSA-N 1-[2-[3-(4-hydroxyphenyl)-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]ethyl]-4-phenylpiperidine-4-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCN3CCC(CC3)(C(N)=O)C=3C=CC=CC=3)(CC2)C=2C=CC(O)=CC=2)=C1 CRJKLZNSICTFRV-UHFFFAOYSA-N 0.000 description 1
- LRTQIIFDSCDLEM-UHFFFAOYSA-N 1-[3-[3-(3,4-dichlorophenyl)-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]propyl]-4-phenylpiperidine-4-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCCN3CCC(CC3)(C(N)=O)C=3C=CC=CC=3)(CC2)C=2C=C(Cl)C(Cl)=CC=2)=C1 LRTQIIFDSCDLEM-UHFFFAOYSA-N 0.000 description 1
- OBVWKFSMKVRHJW-UHFFFAOYSA-N 1-benzyl-4-(3,4-dichlorophenyl)-4-[2-(oxan-2-yloxy)ethyl]pyrrolidin-2-one Chemical compound C1=C(Cl)C(Cl)=CC=C1C1(CCOC2OCCCC2)CC(=O)N(CC=2C=CC=CC=2)C1 OBVWKFSMKVRHJW-UHFFFAOYSA-N 0.000 description 1
- GBJAQCLSQLBKOW-UHFFFAOYSA-N 1-benzyl-4-(4-fluoroanilino)piperidine-4-carbonitrile Chemical compound C1=CC(F)=CC=C1NC1(C#N)CCN(CC=2C=CC=CC=2)CC1 GBJAQCLSQLBKOW-UHFFFAOYSA-N 0.000 description 1
- DICTXEPQAOBPNR-UHFFFAOYSA-N 1-benzyl-4-(4-fluoroanilino)piperidine-4-carboxamide Chemical compound C1CC(C(=O)N)(NC=2C=CC(F)=CC=2)CCN1CC1=CC=CC=C1 DICTXEPQAOBPNR-UHFFFAOYSA-N 0.000 description 1
- DRZUDVTUPHUGFS-UHFFFAOYSA-N 1-benzyl-4-naphthalen-2-yl-4-[2-(oxan-2-yloxy)ethyl]pyrrolidin-2-one Chemical compound C1N(CC=2C=CC=CC=2)C(=O)CC1(C=1C=C2C=CC=CC2=CC=1)CCOC1CCCCO1 DRZUDVTUPHUGFS-UHFFFAOYSA-N 0.000 description 1
- VQQCMQFISIUZMJ-UHFFFAOYSA-N 1-benzylpiperidine-4-carboxamide;hydrochloride Chemical compound Cl.C1CC(C(=O)N)CCN1CC1=CC=CC=C1 VQQCMQFISIUZMJ-UHFFFAOYSA-N 0.000 description 1
- AFWVPEIKHRWQMM-UHFFFAOYSA-N 1-chloro-3-propan-2-yloxybenzene Chemical compound CC(C)OC1=CC=CC(Cl)=C1 AFWVPEIKHRWQMM-UHFFFAOYSA-N 0.000 description 1
- BAZJLYTXTPXMAY-UHFFFAOYSA-N 1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;hydrochloride Chemical compound Cl.C1CNCCC11C(=O)NCN1C1=CC=CC=C1 BAZJLYTXTPXMAY-UHFFFAOYSA-N 0.000 description 1
- IXLCEJNZWAYHPL-UHFFFAOYSA-N 1-phenylpiperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1C1=CC=CC=C1 IXLCEJNZWAYHPL-UHFFFAOYSA-N 0.000 description 1
- DFWVRPAMOYGYDR-UHFFFAOYSA-N 1-pyridin-2-ylpiperidine-4-carboxamide Chemical compound C1CC(C(=O)N)CCN1C1=CC=CC=N1 DFWVRPAMOYGYDR-UHFFFAOYSA-N 0.000 description 1
- XRTANKYQJQXSFP-UHFFFAOYSA-N 1-tert-butyl-4-chlorobenzene Chemical compound CC(C)(C)C1=CC=C(Cl)C=C1 XRTANKYQJQXSFP-UHFFFAOYSA-N 0.000 description 1
- JQNBCSPQVSUBSR-UHFFFAOYSA-N 2,3-dimethoxybenzoyl chloride Chemical compound COC1=CC=CC(C(Cl)=O)=C1OC JQNBCSPQVSUBSR-UHFFFAOYSA-N 0.000 description 1
- KVIUXRJCBBXEGJ-UHFFFAOYSA-N 2,4-dimethoxybenzoyl chloride Chemical compound COC1=CC=C(C(Cl)=O)C(OC)=C1 KVIUXRJCBBXEGJ-UHFFFAOYSA-N 0.000 description 1
- NDXRPDJVAUCBOH-UHFFFAOYSA-N 2,6-dimethoxybenzoyl chloride Chemical compound COC1=CC=CC(OC)=C1C(Cl)=O NDXRPDJVAUCBOH-UHFFFAOYSA-N 0.000 description 1
- DAVJMKMVLKOQQC-UHFFFAOYSA-N 2-(2-fluorophenyl)acetonitrile Chemical compound FC1=CC=CC=C1CC#N DAVJMKMVLKOQQC-UHFFFAOYSA-N 0.000 description 1
- ASLSUMISAQDOOB-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)acetonitrile Chemical compound COC1=CC=C(CC#N)C=C1OC ASLSUMISAQDOOB-UHFFFAOYSA-N 0.000 description 1
- JBGZJQULYGMJGT-UHFFFAOYSA-N 2-(3-phenylpyrrolidin-3-yl)ethanol Chemical compound C=1C=CC=CC=1C1(CCO)CCNC1 JBGZJQULYGMJGT-UHFFFAOYSA-N 0.000 description 1
- LEILLYZQHNCGHP-UHFFFAOYSA-N 2-(3-pyridin-3-ylpyrrolidin-3-yl)ethanol Chemical compound C=1C=CN=CC=1C1(CCO)CCNC1 LEILLYZQHNCGHP-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- AVMSWPWPYJVYKY-UHFFFAOYSA-N 2-Methylpropyl formate Chemical compound CC(C)COC=O AVMSWPWPYJVYKY-UHFFFAOYSA-N 0.000 description 1
- PRMOIYSOKRCXLU-UHFFFAOYSA-N 2-[3-(1,3-benzodioxol-5-yl)phenyl]acetonitrile Chemical compound N#CCC1=CC=CC(C=2C=C3OCOC3=CC=2)=C1 PRMOIYSOKRCXLU-UHFFFAOYSA-N 0.000 description 1
- YULNYKNYQXFRMR-UHFFFAOYSA-N 2-[3-(3,4-dichlorophenyl)-5-oxopyrrolidin-3-yl]acetic acid Chemical compound C=1C=C(Cl)C(Cl)=CC=1C1(CC(=O)O)CNC(=O)C1 YULNYKNYQXFRMR-UHFFFAOYSA-N 0.000 description 1
- NUKWGTHKYWLPEZ-UHFFFAOYSA-N 2-[3-(3,4-dimethoxyphenyl)pyrrolidin-3-yl]ethanol Chemical compound C1=C(OC)C(OC)=CC=C1C1(CCO)CNCC1 NUKWGTHKYWLPEZ-UHFFFAOYSA-N 0.000 description 1
- JOIYKSLWXLFGGR-UHFFFAOYSA-N 2-[3-(trifluoromethyl)phenyl]acetonitrile Chemical compound FC(F)(F)C1=CC=CC(CC#N)=C1 JOIYKSLWXLFGGR-UHFFFAOYSA-N 0.000 description 1
- TZQJUKRQUZTXMC-UHFFFAOYSA-N 2-[3-phenyl-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]ethyl methanesulfonate Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCOS(C)(=O)=O)(CC2)C=2C=CC=CC=2)=C1 TZQJUKRQUZTXMC-UHFFFAOYSA-N 0.000 description 1
- QNKOCFJZJWOXDE-UHFFFAOYSA-N 2-[4-(trifluoromethyl)phenyl]acetonitrile Chemical compound FC(F)(F)C1=CC=C(CC#N)C=C1 QNKOCFJZJWOXDE-UHFFFAOYSA-N 0.000 description 1
- QIKJUFIQSFBDKO-UHFFFAOYSA-N 2-[4-benzyl-3-(3,4-dichlorophenyl)-5-oxopyrrolidin-3-yl]ethyl methanesulfonate Chemical compound C=1C=C(Cl)C(Cl)=CC=1C1(CCOS(=O)(=O)C)CNC(=O)C1CC1=CC=CC=C1 QIKJUFIQSFBDKO-UHFFFAOYSA-N 0.000 description 1
- VKPPFDPXZWFDFA-UHFFFAOYSA-N 2-chloroethanamine Chemical compound NCCCl VKPPFDPXZWFDFA-UHFFFAOYSA-N 0.000 description 1
- SVDDJQGVOFZBNX-UHFFFAOYSA-N 2-chloroethyl carbonochloridate Chemical compound ClCCOC(Cl)=O SVDDJQGVOFZBNX-UHFFFAOYSA-N 0.000 description 1
- 125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- RNONYLFHGJLNEP-UHFFFAOYSA-N 2-naphthalen-2-yl-4-(oxan-2-yloxy)butanenitrile Chemical compound C=1C=C2C=CC=CC2=CC=1C(C#N)CCOC1CCCCO1 RNONYLFHGJLNEP-UHFFFAOYSA-N 0.000 description 1
- OFKQCZBBTSYSPD-UHFFFAOYSA-N 2-naphthalen-2-ylpentanoic acid Chemical compound C1=CC=CC2=CC(C(C(O)=O)CCC)=CC=C21 OFKQCZBBTSYSPD-UHFFFAOYSA-N 0.000 description 1
- GOEBEEJCYYXSFT-UHFFFAOYSA-N 2-phenylpentanedioic acid Chemical compound OC(=O)CCC(C(O)=O)C1=CC=CC=C1 GOEBEEJCYYXSFT-UHFFFAOYSA-N 0.000 description 1
- UKVQBONVSSLJBB-UHFFFAOYSA-N 2-pyridin-2-ylacetonitrile Chemical compound N#CCC1=CC=CC=N1 UKVQBONVSSLJBB-UHFFFAOYSA-N 0.000 description 1
- CXDHJGCWMIOAQP-UHFFFAOYSA-N 2-pyridin-3-yl-1,4,5,6-tetrahydropyrimidine;hydrochloride Chemical compound Cl.C1CCNC(C=2C=NC=CC=2)=N1 CXDHJGCWMIOAQP-UHFFFAOYSA-N 0.000 description 1
- BMVSAKPRNWZCPG-UHFFFAOYSA-N 2-pyridin-4-ylacetonitrile Chemical compound N#CCC1=CC=NC=C1 BMVSAKPRNWZCPG-UHFFFAOYSA-N 0.000 description 1
- CLSHQIDDCJTHAJ-UHFFFAOYSA-N 2-thienylacetonitrile Chemical compound N#CCC1=CC=CS1 CLSHQIDDCJTHAJ-UHFFFAOYSA-N 0.000 description 1
- JUICNMLFNLOFMZ-UHFFFAOYSA-N 3,4,5-triethoxybenzoyl chloride Chemical compound CCOC1=CC(C(Cl)=O)=CC(OCC)=C1OCC JUICNMLFNLOFMZ-UHFFFAOYSA-N 0.000 description 1
- 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
- WAKMMQSMEDJRRI-UHFFFAOYSA-N 3,5-bis(trifluoromethyl)benzoyl chloride Chemical compound FC(F)(F)C1=CC(C(Cl)=O)=CC(C(F)(F)F)=C1 WAKMMQSMEDJRRI-UHFFFAOYSA-N 0.000 description 1
- NXWLBUDWERFLSS-UHFFFAOYSA-N 3-(1-benzyl-3-naphthalen-2-yl-5-oxopyrrolidin-3-yl)propane-1-sulfonic acid Chemical compound O=C1CC(CCCS(=O)(=O)O)(C=2C=C3C=CC=CC3=CC=2)CN1CC1=CC=CC=C1 NXWLBUDWERFLSS-UHFFFAOYSA-N 0.000 description 1
- VGUWZCUCNQXGBU-UHFFFAOYSA-N 3-[(4-methylpiperazin-1-yl)methyl]-5-nitro-1h-indole Chemical compound C1CN(C)CCN1CC1=CNC2=CC=C([N+]([O-])=O)C=C12 VGUWZCUCNQXGBU-UHFFFAOYSA-N 0.000 description 1
- RZXHWQOVYWDEKW-UHFFFAOYSA-N 3-[3-pyridin-3-yl-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]propane-1-sulfonic acid Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCCS(O)(=O)=O)(CC2)C=2C=NC=CC=2)=C1 RZXHWQOVYWDEKW-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical class NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- PHFDWXYATCVIDN-UHFFFAOYSA-N 3-benzyl-1-(4-fluorophenyl)-1,3,8-triazaspiro[4.5]decan-4-one Chemical compound C1=CC(F)=CC=C1N1C2(CCNCC2)C(=O)N(CC=2C=CC=CC=2)C1 PHFDWXYATCVIDN-UHFFFAOYSA-N 0.000 description 1
- AUMUVDNMMXAMAM-UHFFFAOYSA-N 3-benzyl-1-(4-fluorophenyl)-1,3,8-triazaspiro[4.5]decane-2,4-dione Chemical compound C1=CC(F)=CC=C1N1C2(CCNCC2)C(=O)N(CC=2C=CC=CC=2)C1=O AUMUVDNMMXAMAM-UHFFFAOYSA-N 0.000 description 1
- KYYMXJNZLFZJOU-UHFFFAOYSA-N 3-benzyl-8-[2-[3-(3,4-dichlorophenyl)-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]ethyl]-1-(4-fluorophenyl)-1,3,8-triazaspiro[4.5]decan-4-one Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCN3CCC4(CC3)C(N(CC=3C=CC=CC=3)CN4C=3C=CC(F)=CC=3)=O)(CC2)C=2C=C(Cl)C(Cl)=CC=2)=C1 KYYMXJNZLFZJOU-UHFFFAOYSA-N 0.000 description 1
- RUQIUASLAXJZIE-UHFFFAOYSA-N 3-methoxybenzoyl chloride Chemical compound COC1=CC=CC(C(Cl)=O)=C1 RUQIUASLAXJZIE-UHFFFAOYSA-N 0.000 description 1
- USLIRRDZCYCNQT-UHFFFAOYSA-N 4-(2-hydroxyethyl)pyrrolidin-2-one Chemical compound OCCC1CNC(=O)C1 USLIRRDZCYCNQT-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- APIIIPKQPKSIHU-UHFFFAOYSA-N 4-benzyl-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidine-4-carboxylic acid Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1(C(O)=O)CC1=CC=CC=C1 APIIIPKQPKSIHU-UHFFFAOYSA-N 0.000 description 1
- RHBMAGYKGPWMFZ-UHFFFAOYSA-N 4-benzylpiperidine-4-carboxamide Chemical compound C=1C=CC=CC=1CC1(C(=O)N)CCNCC1 RHBMAGYKGPWMFZ-UHFFFAOYSA-N 0.000 description 1
- RKIDDEGICSMIJA-UHFFFAOYSA-N 4-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C=C1 RKIDDEGICSMIJA-UHFFFAOYSA-N 0.000 description 1
- KRZCOLNOCZKSDF-UHFFFAOYSA-N 4-fluoroaniline Chemical compound NC1=CC=C(F)C=C1 KRZCOLNOCZKSDF-UHFFFAOYSA-N 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- HVBORGQFYCRGAS-UHFFFAOYSA-N 4-phenyl-1-[2-[1-(3-propan-2-yloxybenzoyl)-3-[4-(trifluoromethyl)phenyl]pyrrolidin-3-yl]ethyl]piperidine-4-carboxamide Chemical compound CC(C)OC1=CC=CC(C(=O)N2CC(CCN3CCC(CC3)(C(N)=O)C=3C=CC=CC=3)(CC2)C=2C=CC(=CC=2)C(F)(F)F)=C1 HVBORGQFYCRGAS-UHFFFAOYSA-N 0.000 description 1
- KNGDFSPHGDAAGI-UHFFFAOYSA-N 4-phenyl-1-[2-[3-[3-(trifluoromethyl)phenyl]-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]ethyl]piperidine-4-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCN3CCC(CC3)(C(N)=O)C=3C=CC=CC=3)(CC2)C=2C=C(C=CC=2)C(F)(F)F)=C1 KNGDFSPHGDAAGI-UHFFFAOYSA-N 0.000 description 1
- UVHJSIDFUVBWQC-UHFFFAOYSA-N 4-phenyl-1-[2-[3-phenyl-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]ethyl]piperidine-4-carboxamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCN3CCC(CC3)(C(N)=O)C=3C=CC=CC=3)(CC2)C=2C=CC=CC=2)=C1 UVHJSIDFUVBWQC-UHFFFAOYSA-N 0.000 description 1
- UTBULQCHEUWJNV-UHFFFAOYSA-N 4-phenylpiperidine Chemical compound C1CNCCC1C1=CC=CC=C1 UTBULQCHEUWJNV-UHFFFAOYSA-N 0.000 description 1
- VRJHQPZVIGNGMX-UHFFFAOYSA-N 4-piperidinone Chemical compound O=C1CCNCC1 VRJHQPZVIGNGMX-UHFFFAOYSA-N 0.000 description 1
- VXQVGWZSCZUOKK-UHFFFAOYSA-N 4-pyridin-2-ylpiperidine-4-carbonitrile Chemical compound C=1C=CC=NC=1C1(C#N)CCNCC1 VXQVGWZSCZUOKK-UHFFFAOYSA-N 0.000 description 1
- SMDVDDISQIOLCV-UHFFFAOYSA-N 4-pyridin-2-ylpiperidine-4-carbonitrile;hydrochloride Chemical compound Cl.C=1C=CC=NC=1C1(C#N)CCNCC1 SMDVDDISQIOLCV-UHFFFAOYSA-N 0.000 description 1
- ZLHCIPROUHAEFT-UHFFFAOYSA-N 4-pyridin-2-ylpiperidine-4-carboxylic acid;hydrochloride Chemical compound Cl.C=1C=CC=NC=1C1(C(=O)O)CCNCC1 ZLHCIPROUHAEFT-UHFFFAOYSA-N 0.000 description 1
- UUEKRSHAYJJDAV-UHFFFAOYSA-N 4-pyridin-3-ylpiperidine-4-carboxamide Chemical compound C=1C=CN=CC=1C1(C(=O)N)CCNCC1 UUEKRSHAYJJDAV-UHFFFAOYSA-N 0.000 description 1
- QWCYYVYFQUMCIT-UHFFFAOYSA-N 4-pyridin-3-ylpiperidine-4-carboxamide;hydrochloride Chemical compound Cl.C=1C=CN=CC=1C1(C(=O)N)CCNCC1 QWCYYVYFQUMCIT-UHFFFAOYSA-N 0.000 description 1
- IYWFAGSJOGIEED-UHFFFAOYSA-N 4-pyridin-4-ylpiperidine-4-carboxamide;hydrochloride Chemical compound Cl.C=1C=NC=CC=1C1(C(=O)N)CCNCC1 IYWFAGSJOGIEED-UHFFFAOYSA-N 0.000 description 1
- JYRVTGVTAQBXPE-UHFFFAOYSA-N 4-pyridin-4-ylpiperidine-4-carboxylic acid;hydrochloride Chemical compound Cl.C=1C=NC=CC=1C1(C(=O)O)CCNCC1 JYRVTGVTAQBXPE-UHFFFAOYSA-N 0.000 description 1
- WNLMYNASWOULQY-UHFFFAOYSA-N 4-tert-butylbenzoyl chloride Chemical compound CC(C)(C)C1=CC=C(C(Cl)=O)C=C1 WNLMYNASWOULQY-UHFFFAOYSA-N 0.000 description 1
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 1
- KCFLDXPYPAKRND-UHFFFAOYSA-N 5-chloro-1,2,3-trimethoxybenzene Chemical compound COC1=CC(Cl)=CC(OC)=C1OC KCFLDXPYPAKRND-UHFFFAOYSA-N 0.000 description 1
- KGDKHLHDDRKQQP-UHFFFAOYSA-N 8-[2-[3-(3,4-dichlorophenyl)-1-(2,6-dimethoxybenzoyl)pyrrolidin-3-yl]ethyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one Chemical compound COC1=CC=CC(OC)=C1C(=O)N1CC(CCN2CCC3(CC2)C(NCN3C=2C=CC=CC=2)=O)(C=2C=C(Cl)C(Cl)=CC=2)CC1 KGDKHLHDDRKQQP-UHFFFAOYSA-N 0.000 description 1
- LRWCPZAEVSBUKL-UHFFFAOYSA-N 8-[2-[3-(3,4-dichlorophenyl)-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]ethyl]-1-(4-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-2-en-4-one Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCN3CCC4(CC3)C(N=CN4C=3C=CC(F)=CC=3)=O)(CC2)C=2C=C(Cl)C(Cl)=CC=2)=C1 LRWCPZAEVSBUKL-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- ZYFPEHFHDLURJW-UHFFFAOYSA-N C(#N)C(CC(=O)O)(CC(=O)O)C1=CC2=C(OCO2)C=C1 Chemical compound C(#N)C(CC(=O)O)(CC(=O)O)C1=CC2=C(OCO2)C=C1 ZYFPEHFHDLURJW-UHFFFAOYSA-N 0.000 description 1
- RPWNEIIBNMUHAO-UHFFFAOYSA-N C(#N)C(CC(=O)O)(CC(=O)O)C1=CC2=CC=CC=C2C=C1 Chemical compound C(#N)C(CC(=O)O)(CC(=O)O)C1=CC2=CC=CC=C2C=C1 RPWNEIIBNMUHAO-UHFFFAOYSA-N 0.000 description 1
- MIXPBUUMDBVRHM-UHFFFAOYSA-N C(#N)C(CC(=O)O)(CC(=O)O)C=1SC=CC1 Chemical compound C(#N)C(CC(=O)O)(CC(=O)O)C=1SC=CC1 MIXPBUUMDBVRHM-UHFFFAOYSA-N 0.000 description 1
- JVCPKQOUYBMTAD-UHFFFAOYSA-N C1=C(C=CC2=CC=CC=C12)C1NCCC1C(C)O Chemical compound C1=C(C=CC2=CC=CC=C12)C1NCCC1C(C)O JVCPKQOUYBMTAD-UHFFFAOYSA-N 0.000 description 1
- HWYPUQHTKDKZAY-UHFFFAOYSA-N C1=CC(=CN=C1)C(CC(=O)O)(CC(=O)O)C#N Chemical compound C1=CC(=CN=C1)C(CC(=O)O)(CC(=O)O)C#N HWYPUQHTKDKZAY-UHFFFAOYSA-N 0.000 description 1
- JXWHDPGAAMGWDA-UHFFFAOYSA-N CC(C)OC1=CC=CC(C(N(CC2)CC2(CCN(CC2)CCC2(C(O)=O)C2=CC=CC=C2)C2=CC=C(C(F)(F)F)C=C2)=O)=C1 Chemical compound CC(C)OC1=CC=CC(C(N(CC2)CC2(CCN(CC2)CCC2(C(O)=O)C2=CC=CC=C2)C2=CC=C(C(F)(F)F)C=C2)=O)=C1 JXWHDPGAAMGWDA-UHFFFAOYSA-N 0.000 description 1
- GFTUJTSCQQSOAH-UHFFFAOYSA-N COC1=CC(=C(C=C1)C(=O)N2CCC(C2)(CCN3CCC(CC3)C4=CC=CC=C4)C5=CC(=C(C=C5)Cl)Cl)OC Chemical compound COC1=CC(=C(C=C1)C(=O)N2CCC(C2)(CCN3CCC(CC3)C4=CC=CC=C4)C5=CC(=C(C=C5)Cl)Cl)OC GFTUJTSCQQSOAH-UHFFFAOYSA-N 0.000 description 1
- 101100294115 Caenorhabditis elegans nhr-4 gene Proteins 0.000 description 1
- 101100079984 Caenorhabditis elegans nhr-9 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical group NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- MNFWUWSLEDDVNX-UHFFFAOYSA-N Cl.C(#N)C1(CCNCC1)C1=CC=CC=C1.Cl Chemical compound Cl.C(#N)C1(CCNCC1)C1=CC=CC=C1.Cl MNFWUWSLEDDVNX-UHFFFAOYSA-N 0.000 description 1
- DDMVTXKPSOTXAF-UHFFFAOYSA-N Cl.N1=CC=C(C=C1)N1CCC(CC1)C(=O)N Chemical compound Cl.N1=CC=C(C=C1)N1CCC(CC1)C(=O)N DDMVTXKPSOTXAF-UHFFFAOYSA-N 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 101000746263 Conus leopardus Conotoxin Lp5.1 Proteins 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 102100031375 Endothelial lipase Human genes 0.000 description 1
- ICMAFTSLXCXHRK-UHFFFAOYSA-N Ethyl pentanoate Chemical compound CCCCC(=O)OCC ICMAFTSLXCXHRK-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 238000005967 Finkelstein reaction Methods 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229910010082 LiAlH Inorganic materials 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- TZYWCYJVHRLUCT-VABKMULXSA-N N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal Chemical compound CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1 TZYWCYJVHRLUCT-VABKMULXSA-N 0.000 description 1
- IUHOWARQLHPAMP-UHFFFAOYSA-N N1=CC(=CC=C1)C1(CNC(C1)=O)CC(=O)O Chemical compound N1=CC(=CC=C1)C1(CNC(C1)=O)CC(=O)O IUHOWARQLHPAMP-UHFFFAOYSA-N 0.000 description 1
- 108010040716 Neurokinin-3 Receptors Proteins 0.000 description 1
- 102000002003 Neurokinin-3 Receptors Human genes 0.000 description 1
- 101100123346 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) hh2a gene Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- VKFCIVIDFGCOEN-UHFFFAOYSA-N OC(=O)CC(CC(O)=O)(C#N)C1=CC=C(C(F)(F)F)C=C1 Chemical compound OC(=O)CC(CC(O)=O)(C#N)C1=CC=C(C(F)(F)F)C=C1 VKFCIVIDFGCOEN-UHFFFAOYSA-N 0.000 description 1
- XOFRFMSGQRQKHJ-UHFFFAOYSA-N OCCC1(C=CN=C1)C1=CC(Cl)=C(Cl)C=C1 Chemical compound OCCC1(C=CN=C1)C1=CC(Cl)=C(Cl)C=C1 XOFRFMSGQRQKHJ-UHFFFAOYSA-N 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010047141 Vasodilatation Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- QCMCTLMFRNSKQP-UHFFFAOYSA-N [3,5-bis(trifluoromethyl)phenyl]-[3-(3,4-dichlorophenyl)-3-(2-hydroxyethyl)pyrrolidin-1-yl]methanone Chemical compound C1C(CCO)(C=2C=C(Cl)C(Cl)=CC=2)CCN1C(=O)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 QCMCTLMFRNSKQP-UHFFFAOYSA-N 0.000 description 1
- YIPFXCNXLDSBKN-UHFFFAOYSA-N [3-(2-fluorophenyl)-3-(2-hydroxyethyl)pyrrolidin-1-yl]-(3,4,5-trimethoxyphenyl)methanone Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCO)(CC2)C=2C(=CC=CC=2)F)=C1 YIPFXCNXLDSBKN-UHFFFAOYSA-N 0.000 description 1
- GBBUMCPPPOVART-UHFFFAOYSA-N [3-(2-hydroxyethyl)-3-[3-(trifluoromethyl)phenyl]pyrrolidin-1-yl]-(3,4,5-trimethoxyphenyl)methanone Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCO)(CC2)C=2C=C(C=CC=2)C(F)(F)F)=C1 GBBUMCPPPOVART-UHFFFAOYSA-N 0.000 description 1
- YLBFSFAPNOFQDD-UHFFFAOYSA-N [3-(2-hydroxyethyl)-3-[4-(trifluoromethyl)phenyl]pyrrolidin-1-yl]-(3-propan-2-yloxyphenyl)methanone Chemical compound CC(C)OC1=CC=CC(C(=O)N2CC(CCO)(CC2)C=2C=CC(=CC=2)C(F)(F)F)=C1 YLBFSFAPNOFQDD-UHFFFAOYSA-N 0.000 description 1
- PLJXMNLOGSCANL-UHFFFAOYSA-N [3-(2-hydroxyethyl)-3-phenylpyrrolidin-1-yl]-(3,4,5-trimethoxyphenyl)methanone Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCO)(CC2)C=2C=CC=CC=2)=C1 PLJXMNLOGSCANL-UHFFFAOYSA-N 0.000 description 1
- DWPDYYMLPANRKC-UHFFFAOYSA-N [3-(2-hydroxyethyl)-3-pyridin-3-ylpyrrolidin-1-yl]-(3,4,5-trimethoxyphenyl)methanone Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCO)(CC2)C=2C=NC=CC=2)=C1 DWPDYYMLPANRKC-UHFFFAOYSA-N 0.000 description 1
- OJLUGILITBISPE-UHFFFAOYSA-N [3-(3,4-dichlorophenyl)-3-(2-hydroxyethyl)pyrrolidin-1-yl]-pyridin-2-ylmethanone Chemical compound C1C(CCO)(C=2C=C(Cl)C(Cl)=CC=2)CCN1C(=O)C1=CC=CC=N1 OJLUGILITBISPE-UHFFFAOYSA-N 0.000 description 1
- AVQIROZUSWFRAC-UHFFFAOYSA-N [3-[4-[tert-butyl(dimethyl)silyl]oxyphenyl]-3-(2-hydroxyethyl)pyrrolidin-1-yl]-(3,4,5-trimethoxyphenyl)methanone Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CC(CCO)(CC2)C=2C=CC(O[Si](C)(C)C(C)(C)C)=CC=2)=C1 AVQIROZUSWFRAC-UHFFFAOYSA-N 0.000 description 1
- 241000179532 [Candida] cylindracea Species 0.000 description 1
- JFBZPFYRPYOZCQ-UHFFFAOYSA-N [Li].[Al] Chemical compound [Li].[Al] JFBZPFYRPYOZCQ-UHFFFAOYSA-N 0.000 description 1
- WREOTYWODABZMH-DTZQCDIJSA-N [[(2r,3s,4r,5r)-3,4-dihydroxy-5-[2-oxo-4-(2-phenylethoxyamino)pyrimidin-1-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N(C=C\1)C(=O)NC/1=N\OCCC1=CC=CC=C1 WREOTYWODABZMH-DTZQCDIJSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 210000005091 airway smooth muscle Anatomy 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 150000001502 aryl halides Chemical class 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical class [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- UKXSKSHDVLQNKG-UHFFFAOYSA-N benzilic acid Chemical compound C=1C=CC=CC=1C(O)(C(=O)O)C1=CC=CC=C1 UKXSKSHDVLQNKG-UHFFFAOYSA-N 0.000 description 1
- KXHPPCXNWTUNSB-UHFFFAOYSA-M benzyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1=CC=CC=C1 KXHPPCXNWTUNSB-UHFFFAOYSA-M 0.000 description 1
- 238000005574 benzylation reaction Methods 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- XGIUDIMNNMKGDE-UHFFFAOYSA-N bis(trimethylsilyl)azanide Chemical compound C[Si](C)(C)[N-][Si](C)(C)C XGIUDIMNNMKGDE-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- KDPAWGWELVVRCH-UHFFFAOYSA-M bromoacetate Chemical compound [O-]C(=O)CBr KDPAWGWELVVRCH-UHFFFAOYSA-M 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000004044 bronchoconstricting agent Substances 0.000 description 1
- 230000003435 bronchoconstrictive effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- NRDQFWXVTPZZAZ-UHFFFAOYSA-N butyl carbonochloridate Chemical compound CCCCOC(Cl)=O NRDQFWXVTPZZAZ-UHFFFAOYSA-N 0.000 description 1
- KVNRLNFWIYMESJ-UHFFFAOYSA-N butyronitrile Chemical compound CCCC#N KVNRLNFWIYMESJ-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- RBHJBMIOOPYDBQ-UHFFFAOYSA-N carbon dioxide;propan-2-one Chemical compound O=C=O.CC(C)=O RBHJBMIOOPYDBQ-UHFFFAOYSA-N 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229940125758 compound 15 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- SQPQSFMSGIGEIN-UHFFFAOYSA-N dec-2-en-4-one;hydrochloride Chemical compound Cl.CCCCCCC(=O)C=CC SQPQSFMSGIGEIN-UHFFFAOYSA-N 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- ZFTFAPZRGNKQPU-UHFFFAOYSA-N dicarbonic acid Chemical compound OC(=O)OC(O)=O ZFTFAPZRGNKQPU-UHFFFAOYSA-N 0.000 description 1
- 125000003963 dichloro group Chemical group Cl* 0.000 description 1
- 239000002027 dichloromethane extract Substances 0.000 description 1
- PDBUTAOXOIOXGS-UHFFFAOYSA-N diethyl 3-cyano-3-pyridin-3-ylpentanedioate Chemical compound CCOC(=O)CC(CC(=O)OCC)(C#N)C1=CC=CN=C1 PDBUTAOXOIOXGS-UHFFFAOYSA-N 0.000 description 1
- GJZUQUUVIFZTPE-UHFFFAOYSA-N diethyl 3-cyano-3-thiophen-2-ylpentanedioate Chemical compound CCOC(=O)CC(CC(=O)OCC)(C#N)C1=CC=CS1 GJZUQUUVIFZTPE-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- XTDYIOOONNVFMA-UHFFFAOYSA-N dimethyl pentanedioate Chemical compound COC(=O)CCCC(=O)OC XTDYIOOONNVFMA-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- XBRDBODLCHKXHI-UHFFFAOYSA-N epolamine Chemical class OCCN1CCCC1 XBRDBODLCHKXHI-UHFFFAOYSA-N 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- IYFCAAUQJJZDHW-UHFFFAOYSA-N ethyl 1-ethylpiperidine-4-carboxylate Chemical compound CCOC(=O)C1CCN(CC)CC1 IYFCAAUQJJZDHW-UHFFFAOYSA-N 0.000 description 1
- DDDPTEXHUWWNSY-UHFFFAOYSA-N ethyl 2-(5-oxo-3-phenylpyrrolidin-3-yl)acetate Chemical compound C=1C=CC=CC=1C1(CC(=O)OCC)CNC(=O)C1 DDDPTEXHUWWNSY-UHFFFAOYSA-N 0.000 description 1
- AWWGMPHSGWMLSZ-UHFFFAOYSA-N ethyl 2-(5-oxo-3-pyridin-3-ylpyrrolidin-3-yl)acetate Chemical compound C=1C=CN=CC=1C1(CC(=O)OCC)CNC(=O)C1 AWWGMPHSGWMLSZ-UHFFFAOYSA-N 0.000 description 1
- SSUDDXRVYRXUEY-UHFFFAOYSA-N ethyl 2-(5-oxo-3-thiophen-2-ylpyrrolidin-3-yl)acetate Chemical compound C=1C=CSC=1C1(CC(=O)OCC)CNC(=O)C1 SSUDDXRVYRXUEY-UHFFFAOYSA-N 0.000 description 1
- MVUAWCZMIZJRQB-UHFFFAOYSA-N ethyl 2-[3-(1,3-benzodioxol-5-yl)-5-oxopyrrolidin-3-yl]acetate Chemical compound C=1C=C2OCOC2=CC=1C1(CC(=O)OCC)CNC(=O)C1 MVUAWCZMIZJRQB-UHFFFAOYSA-N 0.000 description 1
- XUZADJKKEYDQMJ-UHFFFAOYSA-N ethyl 2-[3-(3,4-dimethoxyphenyl)-5-oxopyrrolidin-3-yl]acetate Chemical compound C=1C=C(OC)C(OC)=CC=1C1(CC(=O)OCC)CNC(=O)C1 XUZADJKKEYDQMJ-UHFFFAOYSA-N 0.000 description 1
- VCLTWQULCRLJKM-UHFFFAOYSA-N ethyl 2-[3-[4-[tert-butyl(dimethyl)silyl]oxyphenyl]-5-oxopyrrolidin-3-yl]acetate Chemical compound C=1C=C(O[Si](C)(C)C(C)(C)C)C=CC=1C1(CC(=O)OCC)CNC(=O)C1 VCLTWQULCRLJKM-UHFFFAOYSA-N 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- IYWCBYFJFZCCGV-UHFFFAOYSA-N formamide;hydrate Chemical compound O.NC=O IYWCBYFJFZCCGV-UHFFFAOYSA-N 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 150000004687 hexahydrates Chemical class 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- UWYVPFMHMJIBHE-OWOJBTEDSA-N hydroxymaleic acid group Chemical group O/C(/C(=O)O)=C/C(=O)O UWYVPFMHMJIBHE-OWOJBTEDSA-N 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 235000000396 iron Nutrition 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- FMKOJHQHASLBPH-UHFFFAOYSA-N isopropyl iodide Chemical compound CC(C)I FMKOJHQHASLBPH-UHFFFAOYSA-N 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- YTJXGDYAEOTOCG-UHFFFAOYSA-N lithium;di(propan-2-yl)azanide;oxolane Chemical compound [Li+].C1CCOC1.CC(C)[N-]C(C)C YTJXGDYAEOTOCG-UHFFFAOYSA-N 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229910052751 metal Chemical class 0.000 description 1
- 239000002184 metal Chemical class 0.000 description 1
- LRPCLTPZMUIPFK-UHFFFAOYSA-N methane;sulfuric acid Chemical compound C.OS(O)(=O)=O LRPCLTPZMUIPFK-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- UOAURXFOXHOVOU-UHFFFAOYSA-N methanol;pentane Chemical compound OC.CCCCC UOAURXFOXHOVOU-UHFFFAOYSA-N 0.000 description 1
- OZSJLLVVZFTDEY-HJXLNUONSA-N methyl (2s,3r)-2-amino-3-hydroxybutanoate;hydrochloride Chemical compound Cl.COC(=O)[C@@H](N)[C@@H](C)O OZSJLLVVZFTDEY-HJXLNUONSA-N 0.000 description 1
- PAVLJGNTVTUENA-UHFFFAOYSA-N methyl 1-[2-[3-(3,4-dichlorophenyl)-1-(3,4,5-trimethoxybenzoyl)pyrrolidin-3-yl]ethyl]-4-phenylpiperidine-4-carboxylate Chemical compound C1CC(C(=O)OC)(C=2C=CC=CC=2)CCN1CCC(C1)(C=2C=C(Cl)C(Cl)=CC=2)CCN1C(=O)C1=CC(OC)=C(OC)C(OC)=C1 PAVLJGNTVTUENA-UHFFFAOYSA-N 0.000 description 1
- KUISDPUHRPZRFF-UHFFFAOYSA-N methyl 4-phenylpiperidine-4-carboxylate Chemical compound C=1C=CC=CC=1C1(C(=O)OC)CCNCC1 KUISDPUHRPZRFF-UHFFFAOYSA-N 0.000 description 1
- JVOMWHQIQRRVHY-UHFFFAOYSA-N methyl 4-phenylpiperidine-4-carboxylate 4-phenylpiperidine-4-carboxylic acid dihydrochloride Chemical compound Cl.C1(=CC=CC=C1)C1(CCNCC1)C(=O)O.Cl.COC(=O)C1(CCNCC1)C1=CC=CC=C1 JVOMWHQIQRRVHY-UHFFFAOYSA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- HTZLCTZGXSXMAS-UHFFFAOYSA-N morpholine-4-carboxamide;hydrochloride Chemical compound Cl.NC(=O)N1CCOCC1 HTZLCTZGXSXMAS-UHFFFAOYSA-N 0.000 description 1
- JJZKYGDMIZQQAR-UHFFFAOYSA-N n,n-dimethyl-4-phenylpiperidine-4-carboxamide Chemical compound C=1C=CC=CC=1C1(C(=O)N(C)C)CCNCC1 JJZKYGDMIZQQAR-UHFFFAOYSA-N 0.000 description 1
- ROKCJJLJVBHNEV-UHFFFAOYSA-N n,n-dimethyl-4-phenylpiperidine-4-carboxamide;hydrochloride Chemical compound Cl.C=1C=CC=CC=1C1(C(=O)N(C)C)CCNCC1 ROKCJJLJVBHNEV-UHFFFAOYSA-N 0.000 description 1
- BEWCDVTWUFJSSM-MBMPTNJISA-N n-[(18z)-6-(2-amino-2-oxoethyl)-12-benzyl-9-(1-hydroxyethyl)-3-(hydroxymethyl)-18-[(4-hydroxyphenyl)methylidene]-19,22-dimethyl-15-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1-oxa-4,7,10,13,16,19-hexazacyclodocos-21-yl]-3-(2-pentylphenyl)propanamide Chemical compound CCCCCC1=CC=CC=C1CCC(=O)NC(C(C)OC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC=1C=CC=CC=1)NC(=O)C(CC(C)C)NC\1=O)C(C)O)C(=O)N(C)C/1=C\C1=CC=C(O)C=C1 BEWCDVTWUFJSSM-MBMPTNJISA-N 0.000 description 1
- COCAUCFPFHUGAA-MGNBDDOMSA-N n-[3-[(1s,7s)-5-amino-4-thia-6-azabicyclo[5.1.0]oct-5-en-7-yl]-4-fluorophenyl]-5-chloropyridine-2-carboxamide Chemical compound C=1C=C(F)C([C@@]23N=C(SCC[C@@H]2C3)N)=CC=1NC(=O)C1=CC=C(Cl)C=N1 COCAUCFPFHUGAA-MGNBDDOMSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- NWAUXXOGBZOWEI-UHFFFAOYSA-N n-methyl-1-phenylpiperidine-4-carboxamide Chemical compound C1CC(C(=O)NC)CCN1C1=CC=CC=C1 NWAUXXOGBZOWEI-UHFFFAOYSA-N 0.000 description 1
- QVMRBHWGLLTUSJ-UHFFFAOYSA-N n-methyl-4-phenylpiperidine-4-carboxamide Chemical compound C=1C=CC=CC=1C1(C(=O)NC)CCNCC1 QVMRBHWGLLTUSJ-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 125000005489 p-toluenesulfonic acid group Chemical group 0.000 description 1
- 229910003445 palladium oxide Inorganic materials 0.000 description 1
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 1
- JQPTYAILLJKUCY-UHFFFAOYSA-N palladium(ii) oxide Chemical compound [O-2].[Pd+2] JQPTYAILLJKUCY-UHFFFAOYSA-N 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001991 pathophysiological effect Effects 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 150000004714 phosphonium salts Chemical class 0.000 description 1
- IBBMAWULFFBRKK-UHFFFAOYSA-N picolinamide Chemical compound NC(=O)C1=CC=CC=N1 IBBMAWULFFBRKK-UHFFFAOYSA-N 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 1
- 229910000343 potassium bisulfate Inorganic materials 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- PSAYJRPASWETSH-UHFFFAOYSA-N pyridine-2-carbonyl chloride Chemical compound ClC(=O)C1=CC=CC=N1 PSAYJRPASWETSH-UHFFFAOYSA-N 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- ZDYVRSLAEXCVBX-UHFFFAOYSA-N pyridinium p-toluenesulfonate Chemical compound C1=CC=[NH+]C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1 ZDYVRSLAEXCVBX-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- LCDCPQHFCOBUEF-UHFFFAOYSA-N pyrrolidine-1-carboxamide Chemical compound NC(=O)N1CCCC1 LCDCPQHFCOBUEF-UHFFFAOYSA-N 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000012066 reaction slurry Substances 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- JZWFDVDETGFGFC-UHFFFAOYSA-N salacetamide Chemical group CC(=O)NC(=O)C1=CC=CC=C1O JZWFDVDETGFGFC-UHFFFAOYSA-N 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- LWAFUIRCBRUZNH-UHFFFAOYSA-N sodium cobalt(2+) Chemical compound [Na+].[Co+2] LWAFUIRCBRUZNH-UHFFFAOYSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- PNMPSAWAZLESGV-UHFFFAOYSA-N tert-butyl 3-benzyl-1-(4-fluorophenyl)-4-oxo-1,3,8-triazaspiro[4.5]decane-8-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC21C(=O)N(CC=1C=CC=CC=1)CN2C1=CC=C(F)C=C1 PNMPSAWAZLESGV-UHFFFAOYSA-N 0.000 description 1
- BWQMKZZIUHZCNQ-UHFFFAOYSA-N tert-butyl 4-(dimethylcarbamoyl)-4-phenylpiperidine-1-carboxylate Chemical compound C=1C=CC=CC=1C1(C(=O)N(C)C)CCN(C(=O)OC(C)(C)C)CC1 BWQMKZZIUHZCNQ-UHFFFAOYSA-N 0.000 description 1
- OSWJTGYPTWVSAJ-UHFFFAOYSA-N tert-butyl 4-(methylcarbamoyl)-4-phenylpiperidine-1-carboxylate Chemical compound C=1C=CC=CC=1C1(C(=O)NC)CCN(C(=O)OC(C)(C)C)CC1 OSWJTGYPTWVSAJ-UHFFFAOYSA-N 0.000 description 1
- AJLSVDSSVLNDCX-UHFFFAOYSA-N tert-butyl 4-benzyl-2-ethylpiperidine-1-carboxylate Chemical compound C(C)C1N(CCC(C1)CC1=CC=CC=C1)C(=O)OC(C)(C)C AJLSVDSSVLNDCX-UHFFFAOYSA-N 0.000 description 1
- LSSMYRDXEBWBAC-UHFFFAOYSA-N tert-butyl 4-carbamoyl-4-naphthalen-2-ylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1(C(N)=O)C1=CC=C(C=CC=C2)C2=C1 LSSMYRDXEBWBAC-UHFFFAOYSA-N 0.000 description 1
- JWQHEYQEMMDFST-UHFFFAOYSA-N tert-butyl 4-carbamoyl-4-pyridin-3-ylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1(C(N)=O)C1=CC=CN=C1 JWQHEYQEMMDFST-UHFFFAOYSA-N 0.000 description 1
- JMTRYZLLWRAPGE-UHFFFAOYSA-N tert-butyl 4-cyano-4-naphthalen-2-ylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1(C#N)C1=CC=C(C=CC=C2)C2=C1 JMTRYZLLWRAPGE-UHFFFAOYSA-N 0.000 description 1
- OUILGYJQVAMETA-UHFFFAOYSA-N tert-butyl 4-cyano-4-pyridin-2-ylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1(C#N)C1=CC=CC=N1 OUILGYJQVAMETA-UHFFFAOYSA-N 0.000 description 1
- FDNWDFSSIBIHFC-UHFFFAOYSA-N tert-butyl 4-cyano-4-pyridin-3-ylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1(C#N)C1=CC=CN=C1 FDNWDFSSIBIHFC-UHFFFAOYSA-N 0.000 description 1
- IZZYWTWQOOWXFS-UHFFFAOYSA-N tert-butyl 4-cyano-4-pyridin-4-ylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1(C#N)C1=CC=NC=C1 IZZYWTWQOOWXFS-UHFFFAOYSA-N 0.000 description 1
- WVMBKXUYNBCHPB-UHFFFAOYSA-N tert-butyl 4-pyridin-3-ylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1C1=CC=CN=C1 WVMBKXUYNBCHPB-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- DLIYJYQTVMUHFQ-UHFFFAOYSA-N tert-butyl n-(4-chlorobutan-2-yl)carbamate Chemical compound ClCCC(C)NC(=O)OC(C)(C)C DLIYJYQTVMUHFQ-UHFFFAOYSA-N 0.000 description 1
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 1
- 150000004685 tetrahydrates Chemical class 0.000 description 1
- 150000003527 tetrahydropyrans Chemical group 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- RYVBINGWVJJDPU-UHFFFAOYSA-M tributyl(hexadecyl)phosphanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[P+](CCCC)(CCCC)CCCC RYVBINGWVJJDPU-UHFFFAOYSA-M 0.000 description 1
- LEIMLDGFXIOXMT-UHFFFAOYSA-N trimethylsilyl cyanide Chemical compound C[Si](C)(C)C#N LEIMLDGFXIOXMT-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5860693A | 1993-05-06 | 1993-05-06 | |
US5860693 | 1993-05-06 | ||
US21848394A | 1994-03-28 | 1994-03-28 | |
US21848394 | 1994-03-28 | ||
US22537194A | 1994-04-19 | 1994-04-19 | |
US22537194 | 1994-04-19 | ||
US9404498 | 1994-04-22 | ||
PCT/US1994/004498 WO1994026735A1 (en) | 1993-05-06 | 1994-04-22 | Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists |
Publications (3)
Publication Number | Publication Date |
---|---|
FI955258A0 FI955258A0 (fi) | 1995-11-02 |
FI955258L FI955258L (fi) | 1995-11-30 |
FI113047B true FI113047B (fi) | 2004-02-27 |
Family
ID=27369482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI955258A FI113047B (fi) | 1993-05-06 | 1995-11-02 | Menetelmä takykiniiniantagonisteina käyttökelpoisten substituoitujen pyrrolidin-3-yylialkyyli-piperidiinien valmistamiseksi |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0696280B1 (cs) |
JP (1) | JP3424174B2 (cs) |
CN (1) | CN1081635C (cs) |
AT (1) | ATE158580T1 (cs) |
AU (1) | AU678023B2 (cs) |
CA (1) | CA2160462C (cs) |
DE (1) | DE69405862T2 (cs) |
DK (1) | DK0696280T3 (cs) |
ES (1) | ES2110761T3 (cs) |
FI (1) | FI113047B (cs) |
GR (1) | GR3025475T3 (cs) |
HU (1) | HU224496B1 (cs) |
IL (1) | IL109496A (cs) |
MX (1) | MX9403386A (cs) |
NO (1) | NO309144B1 (cs) |
NZ (1) | NZ267209A (cs) |
TW (1) | TW281675B (cs) |
WO (1) | WO1994026735A1 (cs) |
Families Citing this family (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2717802B1 (fr) * | 1994-03-25 | 1996-06-21 | Sanofi Sa | Nouveaux composés aromatiques, procédé pour leur préparation et compositions pharmaceutiques en contenant. |
JPH10504580A (ja) | 1994-08-25 | 1998-05-06 | メレルファーマスーティカルズ インコーポレイテッド | アレルギー病の処置に有用な新規な置換ピペリジン類 |
EP0714891A1 (en) * | 1994-11-22 | 1996-06-05 | Eli Lilly And Company | Heterocyclic tachykinin receptor antagonists |
FR2728165A1 (fr) * | 1994-12-19 | 1996-06-21 | Oreal | Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene |
FR2728169A1 (fr) * | 1994-12-19 | 1996-06-21 | Oreal | Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales |
FR2729954B1 (fr) * | 1995-01-30 | 1997-08-01 | Sanofi Sa | Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant |
ES2164235T3 (es) * | 1995-03-15 | 2002-02-16 | Aventis Pharma Inc | Derivados de piperazinona sustituidos por un heterociclo que actuan como antagonistas del receptor de taquiquinina. |
AU700693B2 (en) * | 1995-04-13 | 1999-01-14 | Aventis Pharmaceuticals Inc. | Novel substituted piperazine derivatives having tachykinin receptor antagonists activity |
US5661163A (en) * | 1995-06-07 | 1997-08-26 | Merck & Co., Inc. | Alpha-1a adrenergic receptor antagonists |
FR2738245B1 (fr) * | 1995-08-28 | 1997-11-21 | Sanofi Sa | Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant |
FR2738819B1 (fr) * | 1995-09-14 | 1997-12-05 | Sanofi Sa | Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant |
WO1997013514A1 (en) * | 1995-10-10 | 1997-04-17 | Pfizer Inc. | Nk-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy |
US6211199B1 (en) | 1995-11-17 | 2001-04-03 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
HU224225B1 (hu) * | 1995-12-01 | 2005-06-28 | Sankyo Co. Ltd. | Tachikinin receptor antagonista hatású heterociklusos vegyületek, ezek előállítási eljárása és alkalmazásuk gyógyszerkészítmények előállítására |
DK0874843T3 (da) * | 1995-12-20 | 2002-11-25 | Aventis Pharma Inc | Substituerede 4-(1H-benzimidazol-2-yl)(1,4)diazepaner, der er nyttige til behandling af allergisygdomme |
US6423704B2 (en) | 1995-12-20 | 2002-07-23 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases |
US6194406B1 (en) | 1995-12-20 | 2001-02-27 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease |
GB9600235D0 (en) | 1996-01-05 | 1996-03-06 | Pfizer Ltd | Therapeutic agents |
US5922737A (en) * | 1996-02-21 | 1999-07-13 | Hoechst Marion Roussel, Inc. | Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases |
US5932571A (en) * | 1996-02-21 | 1999-08-03 | Hoechst Marion Roussel, Inc. | Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases |
US5998439A (en) * | 1996-02-21 | 1999-12-07 | Hoescht Marion Roussel, Inc. | Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
US5977139A (en) * | 1996-12-15 | 1999-11-02 | Hoechst Marion Roussel, Inc. | Carboxysubstituted cyclic carboxamide derivatives |
US5861417A (en) * | 1996-12-19 | 1999-01-19 | Hoechst Marion Roussel, Inc. | Heterocyclic substituted pyrrolidine amide derivatives |
NZ335975A (en) * | 1996-12-19 | 2000-11-24 | Hoechst Marion Roussel Inc | Heterocyclic substituted pyrrolidine amide derivatives useful in treating respiratory diseases |
DK0946545T3 (da) * | 1996-12-19 | 2001-11-19 | Aventis Pharma Inc | Nye carboxysubstituerede cykliske carboxamidderivater |
BR9809713A (pt) | 1997-05-30 | 2000-07-11 | Sankyo Co | Composto, medicamento e composição compreendendo o mesmo, uso do composto, e, processos para profilaxia ou tratamento de doenças mediadas com taquicinina, para inibir um receptor nk1 e/ou um receptor nk2, e para profilaxia ou tratamento de asma e/ou bronquite, de rinite, de alergia, e, de incontinência urinária |
ID29137A (id) * | 1998-07-27 | 2001-08-02 | Schering Corp | Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1 |
US7163949B1 (en) | 1999-11-03 | 2007-01-16 | Amr Technology, Inc. | 4-phenyl substituted tetrahydroisoquinolines and use thereof |
MXPA02004330A (es) | 1999-11-03 | 2004-07-30 | Albany Molecular Res Inc | Tetrahidroisoquinolinas aril-y heteroaril-sustituidas y uso de las mismas para bloquear la recaptacion de norepinefrina, dopamina y serotonina.. |
BR0112350A (pt) | 2000-07-11 | 2003-06-24 | Albany Molecular Res Inc | Composto, composição farmacêutica, e, método de tratar um animal afligido por um distúrbio neurológico ou psicológico |
ATE402176T1 (de) * | 2002-12-13 | 2008-08-15 | Smithkline Beecham Corp | Pyrrolidin- und azetidinverbindungen alsccr5- antagonisten |
TW200524868A (en) | 2003-07-31 | 2005-08-01 | Zeria Pharm Co Ltd | Benzylamine derivatives |
WO2005037269A1 (ja) * | 2003-10-21 | 2005-04-28 | Dainippon Sumitomo Pharma Co., Ltd. | 新規ピペリジン誘導体 |
GB0412865D0 (en) * | 2004-06-09 | 2004-07-14 | Glaxo Group Ltd | Chemical compounds |
ZA200701232B (en) | 2004-07-15 | 2008-08-27 | Amr Technology Inc | Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
AU2005299852B2 (en) * | 2004-10-22 | 2011-08-04 | Merck Sharp & Dohme Corp. | CGRP receptor antagonists |
CN104922117A (zh) | 2005-03-22 | 2015-09-23 | 阿泽范药品公司 | 用于治疗月经前病症的β-内酰氨基链烷酸 |
US8362075B2 (en) | 2005-05-17 | 2013-01-29 | Merck Sharp & Dohme Corp. | Cyclohexyl sulphones for treatment of cancer |
ZA200800440B (en) | 2005-07-15 | 2009-12-30 | Amr Technology Inc | Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
SI1910346T1 (sl) | 2005-07-19 | 2019-08-30 | Azevan Pharmaceuticals, Inc. | Antagonist beta-laktamil fenilalalina, cisteina in serin vasopresina |
US8293900B2 (en) | 2005-09-29 | 2012-10-23 | Merck Sharp & Dohme Corp | Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
CA2770486C (en) | 2006-09-22 | 2014-07-15 | Merck Sharp & Dohme Corp. | Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer |
US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
CN101190330A (zh) | 2006-11-30 | 2008-06-04 | 深圳市鼎兴生物医药技术开发有限公司 | 胆碱酯酶在拮抗速激肽药物中的应用 |
MX2009007200A (es) | 2007-01-10 | 2009-07-15 | Angeletti P Ist Richerche Bio | Indazoles sustituidos con amida como inhibidores de poli(adp-ribosa)polimerasa (parp). |
BRPI0807972A2 (pt) | 2007-01-24 | 2014-06-10 | Glaxo Group Ltd | Composições farmacêuticas compreendendo 3,5-diamino-6-(2,3-diclofenil)-l,2,4-triazina ou r(-)-2,4-diamino-5-(2,3-diclorofenil)-6-fluorometilpirim idina e uma nk1 |
WO2008120653A1 (ja) | 2007-04-02 | 2008-10-09 | Banyu Pharmaceutical Co., Ltd. | インドールジオン誘導体 |
WO2009002495A1 (en) | 2007-06-27 | 2008-12-31 | Merck & Co., Inc. | 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
AU2009222122A1 (en) | 2008-03-03 | 2009-09-11 | Tiger Pharmatech | Tyrosine kinase inhibitors |
US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
EP2413932A4 (en) | 2009-04-01 | 2012-09-19 | Merck Sharp & Dohme | INHIBITORS OF AKT ACTIVITY |
WO2010132487A1 (en) | 2009-05-12 | 2010-11-18 | Bristol-Myers Squibb Company | CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF |
SG175420A1 (en) | 2009-05-12 | 2011-12-29 | Albany Molecular Res Inc | 7-([1,2,4,]triazolo[1,5,-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4- tetrahydroisoquinoline and use thereof |
CN102458123A (zh) | 2009-05-12 | 2012-05-16 | 阿尔巴尼分子研究公司 | 芳基、杂芳基和杂环取代的四氢异喹啉及其用途 |
EA023838B1 (ru) | 2009-10-14 | 2016-07-29 | Мерк Шарп Энд Домэ Корп. | ЗАМЕЩЕННЫЕ ПИПЕРИДИНЫ, КОТОРЫЕ ПОВЫШАЮТ АКТИВНОСТЬ p53, И ИХ ПРИМЕНЕНИЕ |
US8921394B2 (en) | 2010-04-27 | 2014-12-30 | Merck Sharp & Dohme Corp. | Prolylcarboxypeptidase inhibitors |
EP2584903B1 (en) | 2010-06-24 | 2018-10-24 | Merck Sharp & Dohme Corp. | Novel heterocyclic compounds as erk inhibitors |
AU2011272738B2 (en) | 2010-07-01 | 2015-08-20 | Azevan Pharmaceuticals, Inc. | Methods for treating post traumatic stress disorder |
AU2011285909B2 (en) | 2010-08-02 | 2016-11-10 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) |
US9029341B2 (en) | 2010-08-17 | 2015-05-12 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA) |
EP2608669B1 (en) | 2010-08-23 | 2016-06-22 | Merck Sharp & Dohme Corp. | NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |
WO2012030685A2 (en) | 2010-09-01 | 2012-03-08 | Schering Corporation | Indazole derivatives useful as erk inhibitors |
WO2012036997A1 (en) | 2010-09-16 | 2012-03-22 | Schering Corporation | Fused pyrazole derivatives as novel erk inhibitors |
EP3766975A1 (en) | 2010-10-29 | 2021-01-20 | Sirna Therapeutics, Inc. | Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
EP2654748B1 (en) | 2010-12-21 | 2016-07-27 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as erk inhibitors |
US20140046059A1 (en) | 2011-04-21 | 2014-02-13 | Piramal Enterprises Limited | Process for the preparation of morpholino sulfonyl indole derivatives |
WO2013063214A1 (en) | 2011-10-27 | 2013-05-02 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
WO2013165816A2 (en) | 2012-05-02 | 2013-11-07 | Merck Sharp & Dohme Corp. | SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS |
US9233979B2 (en) | 2012-09-28 | 2016-01-12 | Merck Sharp & Dohme Corp. | Compounds that are ERK inhibitors |
PL2925888T3 (pl) | 2012-11-28 | 2018-03-30 | Merck Sharp & Dohme Corp. | Kompozycje i sposoby do stosowania w leczeniu nowotworów |
WO2014100065A1 (en) | 2012-12-20 | 2014-06-26 | Merck Sharp & Dohme Corp. | Substituted imidazopyridines as hdm2 inhibitors |
WO2014120748A1 (en) | 2013-01-30 | 2014-08-07 | Merck Sharp & Dohme Corp. | 2,6,7,8 substituted purines as hdm2 inhibitors |
WO2015034925A1 (en) | 2013-09-03 | 2015-03-12 | Moderna Therapeutics, Inc. | Circular polynucleotides |
JP7255967B2 (ja) | 2014-03-28 | 2023-04-11 | アゼヴァン ファーマスーティカルズ,インコーポレイテッド | 神経変性疾患を治療するための組成物および方法 |
WO2017005583A1 (en) * | 2015-07-03 | 2017-01-12 | F. Hoffmann-La Roche Ag | Triaza-spirodecanones as ddr1 inhibitors |
WO2018071283A1 (en) | 2016-10-12 | 2018-04-19 | Merck Sharp & Dohme Corp. | Kdm5 inhibitors |
BR112020005107A2 (pt) | 2017-09-15 | 2020-11-03 | Azevan Pharmaceuticals, Inc. | composições e métodos para o tratamento de lesão cerebral |
EP3706747B1 (en) | 2017-11-08 | 2025-09-03 | Merck Sharp & Dohme LLC | Prmt5 inhibitors |
WO2019094311A1 (en) | 2017-11-08 | 2019-05-16 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
US11981701B2 (en) | 2018-08-07 | 2024-05-14 | Merck Sharp & Dohme Llc | PRMT5 inhibitors |
KR20210046009A (ko) | 2018-08-07 | 2021-04-27 | 머크 샤프 앤드 돔 코포레이션 | Prmt5 억제제 |
WO2020033282A1 (en) | 2018-08-07 | 2020-02-13 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL99320A (en) * | 1990-09-05 | 1995-07-31 | Sanofi Sa | Arylalkylamines, their preparation and pharmaceutical compositions containing them |
FR2676055B1 (fr) * | 1991-05-03 | 1993-09-03 | Sanofi Elf | Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant. |
-
1994
- 1994-04-22 AT AT94917898T patent/ATE158580T1/de not_active IP Right Cessation
- 1994-04-22 DK DK94917898.2T patent/DK0696280T3/da active
- 1994-04-22 CA CA002160462A patent/CA2160462C/en not_active Expired - Fee Related
- 1994-04-22 NZ NZ267209A patent/NZ267209A/en unknown
- 1994-04-22 CN CN94192362A patent/CN1081635C/zh not_active Expired - Fee Related
- 1994-04-22 DE DE69405862T patent/DE69405862T2/de not_active Expired - Lifetime
- 1994-04-22 ES ES94917898T patent/ES2110761T3/es not_active Expired - Lifetime
- 1994-04-22 EP EP94917898A patent/EP0696280B1/en not_active Expired - Lifetime
- 1994-04-22 HU HU9503153A patent/HU224496B1/hu not_active IP Right Cessation
- 1994-04-22 AU AU69426/94A patent/AU678023B2/en not_active Ceased
- 1994-04-22 WO PCT/US1994/004498 patent/WO1994026735A1/en active IP Right Grant
- 1994-04-22 JP JP52545394A patent/JP3424174B2/ja not_active Expired - Fee Related
- 1994-04-26 TW TW083103768A patent/TW281675B/zh active
- 1994-05-02 IL IL10949694A patent/IL109496A/xx not_active IP Right Cessation
- 1994-05-06 MX MX9403386A patent/MX9403386A/es unknown
-
1995
- 1995-11-02 FI FI955258A patent/FI113047B/fi not_active IP Right Cessation
- 1995-11-03 NO NO954400A patent/NO309144B1/no not_active IP Right Cessation
-
1997
- 1997-11-26 GR GR970403124T patent/GR3025475T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
FI955258A0 (fi) | 1995-11-02 |
NO954400L (no) | 1996-01-08 |
MX9403386A (es) | 1995-01-31 |
CN1081635C (zh) | 2002-03-27 |
AU678023B2 (en) | 1997-05-15 |
WO1994026735A1 (en) | 1994-11-24 |
HU9503153D0 (en) | 1996-01-29 |
ES2110761T3 (es) | 1998-02-16 |
CN1124961A (zh) | 1996-06-19 |
NO309144B1 (no) | 2000-12-18 |
FI955258L (fi) | 1995-11-30 |
JP3424174B2 (ja) | 2003-07-07 |
DE69405862T2 (de) | 1998-01-15 |
TW281675B (cs) | 1996-07-21 |
HUT74085A (en) | 1996-11-28 |
NO954400D0 (no) | 1995-11-03 |
HU224496B1 (hu) | 2005-10-28 |
IL109496A (en) | 2000-07-26 |
NZ267209A (en) | 1997-09-22 |
IL109496A0 (en) | 1994-08-26 |
ATE158580T1 (de) | 1997-10-15 |
GR3025475T3 (en) | 1998-02-27 |
CA2160462C (en) | 1998-12-15 |
CA2160462A1 (en) | 1994-11-24 |
JPH09500361A (ja) | 1997-01-14 |
EP0696280A1 (en) | 1996-02-14 |
AU6942694A (en) | 1994-12-12 |
DK0696280T3 (da) | 1998-01-12 |
EP0696280B1 (en) | 1997-09-24 |
DE69405862D1 (de) | 1997-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI113047B (fi) | Menetelmä takykiniiniantagonisteina käyttökelpoisten substituoitujen pyrrolidin-3-yylialkyyli-piperidiinien valmistamiseksi | |
US5635510A (en) | Substituted pyrrolidin-3-yl-alkyl-piperidines | |
EP0777666B1 (en) | Substituted piperidines useful for the treatment of allergic diseases | |
EP0850236B1 (en) | Piperazino derivatives as neurokinin antagonists | |
JP5377504B2 (ja) | 置換されたn−フェニル−ピロリジニルメチルピロリジンアミドおよびその治療的用途 | |
US8604046B2 (en) | Substituted piperidine spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof | |
HRP970426A2 (en) | Fluorine containing 1,4-disubstituted piperidine derivatives | |
US20100168088A1 (en) | Pyrrolidine derivatives as nk-3 receptor antagonists | |
EP2212283A1 (en) | Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof | |
JP6173431B2 (ja) | モルヒナン誘導体 | |
EP0937069A1 (en) | Piperazino derivatives as neurokinin antagonists | |
US5824690A (en) | Substituted pyrrolidin-3-yl-alkyl-piperidines | |
KR100468552B1 (ko) | 카르복시 치환된 신규 시클릭 카르복스아미드 유도체 | |
KR100339444B1 (ko) | 타키키닌길항제로서 유용한 치환된 피롤리딘-3-일-알킬-피페리딘 | |
HUP0000315A2 (hu) | Heterociklusos szubsztituált pirrolidin-amid származékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
US20080262041A1 (en) | Beta-Lactams for Treatment of Cns Disorders | |
KR19990044138A (ko) | 뉴로키닌 길항제로서의 피페라지노 유도체 | |
HK1146055B (en) | Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |